CN1198547C - Disposable absorbent article with skin care composition on apertured top sheet - Google Patents
Disposable absorbent article with skin care composition on apertured top sheet Download PDFInfo
- Publication number
- CN1198547C CN1198547C CN 97182507 CN97182507A CN1198547C CN 1198547 C CN1198547 C CN 1198547C CN 97182507 CN97182507 CN 97182507 CN 97182507 A CN97182507 A CN 97182507A CN 1198547 C CN1198547 C CN 1198547C
- Authority
- CN
- China
- Prior art keywords
- absorbent article
- disposable absorbent
- structured carrier
- skin
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 176
- 239000002250 absorbent Substances 0.000 title claims abstract description 121
- 230000002745 absorbent Effects 0.000 title claims abstract description 120
- 239000007788 liquid Substances 0.000 claims abstract description 34
- 239000007787 solid Substances 0.000 claims abstract description 14
- -1 fatty acid esters Chemical class 0.000 claims description 65
- 239000000314 lubricant Substances 0.000 claims description 48
- 239000000834 fixative Substances 0.000 claims description 40
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 30
- 239000000194 fatty acid Substances 0.000 claims description 30
- 229930195729 fatty acid Natural products 0.000 claims description 30
- 239000002480 mineral oil Substances 0.000 claims description 21
- 239000011148 porous material Substances 0.000 claims description 21
- 150000002191 fatty alcohols Chemical class 0.000 claims description 20
- 235000019271 petrolatum Nutrition 0.000 claims description 20
- 229920001296 polysiloxane Polymers 0.000 claims description 20
- 235000010446 mineral oil Nutrition 0.000 claims description 19
- 150000004665 fatty acids Chemical class 0.000 claims description 17
- 239000003795 chemical substances by application Substances 0.000 claims description 16
- 238000002844 melting Methods 0.000 claims description 16
- 230000008018 melting Effects 0.000 claims description 16
- 239000004264 Petrolatum Substances 0.000 claims description 13
- 238000007046 ethoxylation reaction Methods 0.000 claims description 13
- 229940066842 petrolatum Drugs 0.000 claims description 13
- 239000012530 fluid Substances 0.000 claims description 12
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 claims description 12
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 claims description 10
- 239000003208 petroleum Substances 0.000 claims description 9
- 239000012188 paraffin wax Substances 0.000 claims description 7
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 6
- 230000003100 immobilizing effect Effects 0.000 claims description 6
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 claims description 6
- 229960000541 cetyl alcohol Drugs 0.000 claims description 5
- 125000001183 hydrocarbyl group Chemical group 0.000 claims description 5
- 229910052799 carbon Inorganic materials 0.000 claims description 4
- 239000004033 plastic Substances 0.000 claims description 4
- 229920003023 plastic Polymers 0.000 claims description 4
- 229910052739 hydrogen Inorganic materials 0.000 claims description 3
- 229920000728 polyester Polymers 0.000 claims description 3
- 229920005862 polyol Polymers 0.000 claims description 3
- 150000003077 polyols Chemical class 0.000 claims description 3
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 claims description 2
- 238000012546 transfer Methods 0.000 claims description 2
- 230000001681 protective effect Effects 0.000 abstract description 9
- 239000000463 material Substances 0.000 description 33
- 238000000034 method Methods 0.000 description 29
- 239000004094 surface-active agent Substances 0.000 description 25
- 125000000217 alkyl group Chemical group 0.000 description 24
- 230000008901 benefit Effects 0.000 description 19
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 16
- 239000000047 product Substances 0.000 description 16
- 210000002700 urine Anatomy 0.000 description 16
- 239000006210 lotion Substances 0.000 description 15
- 150000005690 diesters Chemical class 0.000 description 13
- 239000000523 sample Substances 0.000 description 12
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 11
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 10
- 238000009826 distribution Methods 0.000 description 10
- 210000002414 leg Anatomy 0.000 description 10
- 239000001993 wax Substances 0.000 description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 9
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 9
- 125000003342 alkenyl group Chemical group 0.000 description 9
- 230000004888 barrier function Effects 0.000 description 9
- 239000007859 condensation product Substances 0.000 description 9
- 239000000126 substance Substances 0.000 description 9
- 239000003974 emollient agent Substances 0.000 description 8
- 229950011392 sorbitan stearate Drugs 0.000 description 8
- 150000005691 triesters Chemical class 0.000 description 8
- 229930006000 Sucrose Natural products 0.000 description 7
- 239000000853 adhesive Substances 0.000 description 7
- 230000001070 adhesive effect Effects 0.000 description 7
- 150000001298 alcohols Chemical class 0.000 description 7
- 125000004432 carbon atom Chemical group C* 0.000 description 7
- 239000003995 emulsifying agent Substances 0.000 description 7
- 210000000416 exudates and transudate Anatomy 0.000 description 7
- 229930195733 hydrocarbon Natural products 0.000 description 7
- 150000002430 hydrocarbons Chemical class 0.000 description 7
- 239000002674 ointment Substances 0.000 description 7
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 7
- 239000005720 sucrose Substances 0.000 description 7
- 238000000576 coating method Methods 0.000 description 6
- 210000003608 fece Anatomy 0.000 description 6
- 239000000835 fiber Substances 0.000 description 6
- 238000005259 measurement Methods 0.000 description 6
- 230000001225 therapeutic effect Effects 0.000 description 6
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 5
- 239000011248 coating agent Substances 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 150000002148 esters Chemical class 0.000 description 5
- 235000011187 glycerol Nutrition 0.000 description 5
- 230000002209 hydrophobic effect Effects 0.000 description 5
- 239000004615 ingredient Substances 0.000 description 5
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 5
- 235000000346 sugar Nutrition 0.000 description 5
- DSEKYWAQQVUQTP-XEWMWGOFSA-N (2r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-2-hydroxy-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1h-picen-3-one Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3C[C@@H](O)C(=O)[C@@H]1C DSEKYWAQQVUQTP-XEWMWGOFSA-N 0.000 description 4
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 4
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 4
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 4
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- 206010021639 Incontinence Diseases 0.000 description 4
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 4
- IYFATESGLOUGBX-YVNJGZBMSA-N Sorbitan monopalmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O IYFATESGLOUGBX-YVNJGZBMSA-N 0.000 description 4
- 235000021355 Stearic acid Nutrition 0.000 description 4
- 240000008042 Zea mays Species 0.000 description 4
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 4
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 4
- OGBUMNBNEWYMNJ-UHFFFAOYSA-N batilol Chemical class CCCCCCCCCCCCCCCCCCOCC(O)CO OGBUMNBNEWYMNJ-UHFFFAOYSA-N 0.000 description 4
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 4
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 229920002678 cellulose Polymers 0.000 description 4
- 235000010980 cellulose Nutrition 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 235000005822 corn Nutrition 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 231100000344 non-irritating Toxicity 0.000 description 4
- 239000002736 nonionic surfactant Substances 0.000 description 4
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 150000005846 sugar alcohols Polymers 0.000 description 4
- 239000006188 syrup Substances 0.000 description 4
- 235000020357 syrup Nutrition 0.000 description 4
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 3
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 3
- 229930091371 Fructose Natural products 0.000 description 3
- 239000005715 Fructose Substances 0.000 description 3
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 3
- 239000004166 Lanolin Substances 0.000 description 3
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 3
- 239000002202 Polyethylene glycol Substances 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 3
- 230000002411 adverse Effects 0.000 description 3
- 238000004364 calculation method Methods 0.000 description 3
- 239000001913 cellulose Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000002131 composite material Substances 0.000 description 3
- 230000003750 conditioning effect Effects 0.000 description 3
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 3
- KPUWHANPEXNPJT-UHFFFAOYSA-N disiloxane Chemical class [SiH3]O[SiH3] KPUWHANPEXNPJT-UHFFFAOYSA-N 0.000 description 3
- SFNALCNOMXIBKG-UHFFFAOYSA-N ethylene glycol monododecyl ether Chemical compound CCCCCCCCCCCCOCCO SFNALCNOMXIBKG-UHFFFAOYSA-N 0.000 description 3
- 125000000524 functional group Chemical group 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 3
- 235000019388 lanolin Nutrition 0.000 description 3
- 229940039717 lanolin Drugs 0.000 description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 3
- 238000004806 packaging method and process Methods 0.000 description 3
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 3
- 229920001223 polyethylene glycol Polymers 0.000 description 3
- 239000003755 preservative agent Substances 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 238000006722 reduction reaction Methods 0.000 description 3
- 235000003441 saturated fatty acids Nutrition 0.000 description 3
- 229950003429 sorbitan palmitate Drugs 0.000 description 3
- 239000000600 sorbitol Substances 0.000 description 3
- 235000010356 sorbitol Nutrition 0.000 description 3
- 239000008117 stearic acid Substances 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- 125000001424 substituent group Chemical group 0.000 description 3
- 150000008163 sugars Chemical class 0.000 description 3
- SVTBMSDMJJWYQN-UHFFFAOYSA-N 2-methylpentane-2,4-diol Chemical compound CC(O)CC(C)(C)O SVTBMSDMJJWYQN-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 2
- 239000005995 Aluminium silicate Substances 0.000 description 2
- 239000004322 Butylated hydroxytoluene Substances 0.000 description 2
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 2
- RKWGIWYCVPQPMF-UHFFFAOYSA-N Chloropropamide Chemical compound CCCNC(=O)NS(=O)(=O)C1=CC=C(Cl)C=C1 RKWGIWYCVPQPMF-UHFFFAOYSA-N 0.000 description 2
- 244000060011 Cocos nucifera Species 0.000 description 2
- 235000013162 Cocos nucifera Nutrition 0.000 description 2
- YTBSYETUWUMLBZ-UHFFFAOYSA-N D-Erythrose Natural products OCC(O)C(O)C=O YTBSYETUWUMLBZ-UHFFFAOYSA-N 0.000 description 2
- YTBSYETUWUMLBZ-IUYQGCFVSA-N D-erythrose Chemical compound OC[C@@H](O)[C@@H](O)C=O YTBSYETUWUMLBZ-IUYQGCFVSA-N 0.000 description 2
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 2
- 206010056474 Erythrosis Diseases 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- FLIACVVOZYBSBS-UHFFFAOYSA-N Methyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC FLIACVVOZYBSBS-UHFFFAOYSA-N 0.000 description 2
- HPEUJPJOZXNMSJ-UHFFFAOYSA-N Methyl stearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC HPEUJPJOZXNMSJ-UHFFFAOYSA-N 0.000 description 2
- 235000021314 Palmitic acid Nutrition 0.000 description 2
- 229920002257 Plurafac® Polymers 0.000 description 2
- 239000004721 Polyphenylene oxide Substances 0.000 description 2
- 239000004743 Polypropylene Substances 0.000 description 2
- IJCWFDPJFXGQBN-RYNSOKOISA-N [(2R)-2-[(2R,3R,4S)-4-hydroxy-3-octadecanoyloxyoxolan-2-yl]-2-octadecanoyloxyethyl] octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](OC(=O)CCCCCCCCCCCCCCCCC)[C@H]1OC[C@H](O)[C@H]1OC(=O)CCCCCCCCCCCCCCCCC IJCWFDPJFXGQBN-RYNSOKOISA-N 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 125000002877 alkyl aryl group Chemical group 0.000 description 2
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 2
- 235000012211 aluminium silicate Nutrition 0.000 description 2
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 2
- 125000003710 aryl alkyl group Chemical group 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- 235000013871 bee wax Nutrition 0.000 description 2
- 239000012166 beeswax Substances 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 2
- 230000036760 body temperature Effects 0.000 description 2
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 2
- 229940095259 butylated hydroxytoluene Drugs 0.000 description 2
- 239000004204 candelilla wax Substances 0.000 description 2
- 235000013868 candelilla wax Nutrition 0.000 description 2
- 229940073532 candelilla wax Drugs 0.000 description 2
- 239000004203 carnauba wax Substances 0.000 description 2
- 235000013869 carnauba wax Nutrition 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- 125000004122 cyclic group Chemical group 0.000 description 2
- 125000000753 cycloalkyl group Chemical group 0.000 description 2
- 238000007405 data analysis Methods 0.000 description 2
- 230000001627 detrimental effect Effects 0.000 description 2
- 239000004205 dimethyl polysiloxane Substances 0.000 description 2
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical compound C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 2
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 2
- ILRSCQWREDREME-UHFFFAOYSA-N dodecanamide Chemical compound CCCCCCCCCCCC(N)=O ILRSCQWREDREME-UHFFFAOYSA-N 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940126534 drug product Drugs 0.000 description 2
- 230000009977 dual effect Effects 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 239000006260 foam Substances 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 229930182830 galactose Natural products 0.000 description 2
- 229940075507 glyceryl monostearate Drugs 0.000 description 2
- 125000003055 glycidyl group Chemical group C(C1CO1)* 0.000 description 2
- 229930182470 glycoside Natural products 0.000 description 2
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 2
- HSEMFIZWXHQJAE-UHFFFAOYSA-N hexadecanamide Chemical compound CCCCCCCCCCCCCCCC(N)=O HSEMFIZWXHQJAE-UHFFFAOYSA-N 0.000 description 2
- 238000010191 image analysis Methods 0.000 description 2
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- 239000004200 microcrystalline wax Substances 0.000 description 2
- 235000019808 microcrystalline wax Nutrition 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 2
- LYRFLYHAGKPMFH-UHFFFAOYSA-N octadecanamide Chemical compound CCCCCCCCCCCCCCCCCC(N)=O LYRFLYHAGKPMFH-UHFFFAOYSA-N 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 239000005022 packaging material Substances 0.000 description 2
- 235000019809 paraffin wax Nutrition 0.000 description 2
- 239000000825 pharmaceutical preparation Substances 0.000 description 2
- 239000002985 plastic film Substances 0.000 description 2
- 229920006255 plastic film Polymers 0.000 description 2
- 229920000570 polyether Polymers 0.000 description 2
- 229920001155 polypropylene Polymers 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 2
- 239000011253 protective coating Substances 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 239000001589 sorbitan tristearate Substances 0.000 description 2
- 235000011078 sorbitan tristearate Nutrition 0.000 description 2
- 229960004129 sorbitan tristearate Drugs 0.000 description 2
- 238000005507 spraying Methods 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 239000012209 synthetic fiber Substances 0.000 description 2
- 229920002994 synthetic fiber Polymers 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- 235000012222 talc Nutrition 0.000 description 2
- HLZKNKRTKFSKGZ-UHFFFAOYSA-N tetradecan-1-ol Chemical compound CCCCCCCCCCCCCCO HLZKNKRTKFSKGZ-UHFFFAOYSA-N 0.000 description 2
- 229920001169 thermoplastic Polymers 0.000 description 2
- 239000004416 thermosoftening plastic Substances 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 238000009736 wetting Methods 0.000 description 2
- 239000000080 wetting agent Substances 0.000 description 2
- QIJRTFXNRTXDIP-UHFFFAOYSA-N (1-carboxy-2-sulfanylethyl)azanium;chloride;hydrate Chemical compound O.Cl.SCC(N)C(O)=O QIJRTFXNRTXDIP-UHFFFAOYSA-N 0.000 description 1
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- WCOXQTXVACYMLM-UHFFFAOYSA-N 2,3-bis(12-hydroxyoctadecanoyloxy)propyl 12-hydroxyoctadecanoate Chemical compound CCCCCCC(O)CCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCC(O)CCCCCC)COC(=O)CCCCCCCCCCC(O)CCCCCC WCOXQTXVACYMLM-UHFFFAOYSA-N 0.000 description 1
- ZEMPKEQAKRGZGQ-AAKVHIHISA-N 2,3-bis[[(z)-12-hydroxyoctadec-9-enoyl]oxy]propyl (z)-12-hydroxyoctadec-9-enoate Chemical compound CCCCCCC(O)C\C=C/CCCCCCCC(=O)OCC(OC(=O)CCCCCCC\C=C/CC(O)CCCCCC)COC(=O)CCCCCCC\C=C/CC(O)CCCCCC ZEMPKEQAKRGZGQ-AAKVHIHISA-N 0.000 description 1
- XFOQWQKDSMIPHT-UHFFFAOYSA-N 2,3-dichloro-6-(trifluoromethyl)pyridine Chemical compound FC(F)(F)C1=CC=C(Cl)C(Cl)=N1 XFOQWQKDSMIPHT-UHFFFAOYSA-N 0.000 description 1
- FKMHSNTVILORFA-UHFFFAOYSA-N 2-[2-(2-dodecoxyethoxy)ethoxy]ethanol Chemical compound CCCCCCCCCCCCOCCOCCOCCO FKMHSNTVILORFA-UHFFFAOYSA-N 0.000 description 1
- HNUQMTZUNUBOLQ-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-[2-[2-[2-(2-octadecoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol Chemical compound CCCCCCCCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO HNUQMTZUNUBOLQ-UHFFFAOYSA-N 0.000 description 1
- JKXYOQDLERSFPT-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2-octadecoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol Chemical compound CCCCCCCCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO JKXYOQDLERSFPT-UHFFFAOYSA-N 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- AMEMLELAMQEAIA-UHFFFAOYSA-N 6-(tert-butyl)thieno[3,2-d]pyrimidin-4(3H)-one Chemical compound N1C=NC(=O)C2=C1C=C(C(C)(C)C)S2 AMEMLELAMQEAIA-UHFFFAOYSA-N 0.000 description 1
- 235000007173 Abies balsamea Nutrition 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 238000012935 Averaging Methods 0.000 description 1
- 239000004857 Balsam Substances 0.000 description 1
- 235000021357 Behenic acid Nutrition 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 229920003043 Cellulose fiber Polymers 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- XZMCDFZZKTWFGF-UHFFFAOYSA-N Cyanamide Chemical compound NC#N XZMCDFZZKTWFGF-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 1
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 206010016322 Feeling abnormal Diseases 0.000 description 1
- 206010016803 Fluid overload Diseases 0.000 description 1
- 229920000926 Galactomannan Polymers 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 244000018716 Impatiens biflora Species 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- SNIOPGDIGTZGOP-UHFFFAOYSA-N Nitroglycerin Chemical compound [O-][N+](=O)OCC(O[N+]([O-])=O)CO[N+]([O-])=O SNIOPGDIGTZGOP-UHFFFAOYSA-N 0.000 description 1
- OQILCOQZDHPEAZ-UHFFFAOYSA-N Palmitinsaeure-octylester Natural products CCCCCCCCCCCCCCCC(=O)OCCCCCCCC OQILCOQZDHPEAZ-UHFFFAOYSA-N 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- 239000004820 Pressure-sensitive adhesive Substances 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- 229920001131 Pulp (paper) Polymers 0.000 description 1
- MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 description 1
- 229920001247 Reticulated foam Polymers 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229920002522 Wood fibre Polymers 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- FMRLDPWIRHBCCC-UHFFFAOYSA-L Zinc carbonate Chemical compound [Zn+2].[O-]C([O-])=O FMRLDPWIRHBCCC-UHFFFAOYSA-L 0.000 description 1
- CEZONBVMFRWNCJ-CYGHRXIMSA-N [(3r,3ar,6s,6ar)-3-hydroxy-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-6-yl] dodecanoate Chemical compound O[C@@H]1CO[C@@H]2[C@@H](OC(=O)CCCCCCCCCCC)CO[C@@H]21 CEZONBVMFRWNCJ-CYGHRXIMSA-N 0.000 description 1
- AMZWNNKNOQSBOP-UHFFFAOYSA-M [n'-(2,5-dioxoimidazolidin-4-yl)carbamimidoyl]oxyaluminum;dihydrate Chemical compound O.O.NC(=O)NC1N=C(O[Al])NC1=O AMZWNNKNOQSBOP-UHFFFAOYSA-M 0.000 description 1
- ZOIORXHNWRGPMV-UHFFFAOYSA-N acetic acid;zinc Chemical compound [Zn].CC(O)=O.CC(O)=O ZOIORXHNWRGPMV-UHFFFAOYSA-N 0.000 description 1
- HDYRYUINDGQKMC-UHFFFAOYSA-M acetyloxyaluminum;dihydrate Chemical compound O.O.CC(=O)O[Al] HDYRYUINDGQKMC-UHFFFAOYSA-M 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 229940015825 aldioxa Drugs 0.000 description 1
- 150000001335 aliphatic alkanes Chemical class 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229940009827 aluminum acetate Drugs 0.000 description 1
- 229940024546 aluminum hydroxide gel Drugs 0.000 description 1
- SNAAJJQQZSMGQD-UHFFFAOYSA-N aluminum magnesium Chemical compound [Mg].[Al] SNAAJJQQZSMGQD-UHFFFAOYSA-N 0.000 description 1
- SMYKVLBUSSNXMV-UHFFFAOYSA-K aluminum;trihydroxide;hydrate Chemical compound O.[OH-].[OH-].[OH-].[Al+3] SMYKVLBUSSNXMV-UHFFFAOYSA-K 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 238000004873 anchoring Methods 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 239000003443 antiviral agent Substances 0.000 description 1
- 229940003587 aquaphor Drugs 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- 229940116224 behenate Drugs 0.000 description 1
- UKMSUNONTOPOIO-UHFFFAOYSA-M behenate Chemical compound CCCCCCCCCCCCCCCCCCCCCC([O-])=O UKMSUNONTOPOIO-UHFFFAOYSA-M 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 235000010290 biphenyl Nutrition 0.000 description 1
- 239000004305 biphenyl Substances 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 125000005998 bromoethyl group Chemical group 0.000 description 1
- 210000001217 buttock Anatomy 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 125000004218 chloromethyl group Chemical group [H]C([H])(Cl)* 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 235000019868 cocoa butter Nutrition 0.000 description 1
- 229940110456 cocoa butter Drugs 0.000 description 1
- 229940096386 coconut alcohol Drugs 0.000 description 1
- 239000003026 cod liver oil Substances 0.000 description 1
- 235000012716 cod liver oil Nutrition 0.000 description 1
- 230000001427 coherent effect Effects 0.000 description 1
- 229940075614 colloidal silicon dioxide Drugs 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 229940086555 cyclomethicone Drugs 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 229960001305 cysteine hydrochloride Drugs 0.000 description 1
- TUTWLYPCGCUWQI-UHFFFAOYSA-N decanamide Chemical compound CCCCCCCCCC(N)=O TUTWLYPCGCUWQI-UHFFFAOYSA-N 0.000 description 1
- 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 230000002939 deleterious effect Effects 0.000 description 1
- 239000002781 deodorant agent Substances 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 229940075960 desitin Drugs 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 1
- 229940008099 dimethicone Drugs 0.000 description 1
- RZHBMYQXKIDANM-UHFFFAOYSA-N dioctyl butanedioate;sodium Chemical compound [Na].CCCCCCCCOC(=O)CCC(=O)OCCCCCCCC RZHBMYQXKIDANM-UHFFFAOYSA-N 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 229960000735 docosanol Drugs 0.000 description 1
- POULHZVOKOAJMA-UHFFFAOYSA-M dodecanoate Chemical compound CCCCCCCCCCCC([O-])=O POULHZVOKOAJMA-UHFFFAOYSA-M 0.000 description 1
- QQQMUBLXDAFBRH-UHFFFAOYSA-N dodecyl 2-hydroxypropanoate Chemical compound CCCCCCCCCCCCOC(=O)C(C)O QQQMUBLXDAFBRH-UHFFFAOYSA-N 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- CAMHHLOGFDZBBG-UHFFFAOYSA-N epoxidized methyl oleate Natural products CCCCCCCCC1OC1CCCCCCCC(=O)OC CAMHHLOGFDZBBG-UHFFFAOYSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- GJQLBGWSDGMZKM-UHFFFAOYSA-N ethylhexyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(CC)CCCCC GJQLBGWSDGMZKM-UHFFFAOYSA-N 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000013213 extrapolation Methods 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 150000002194 fatty esters Chemical class 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 125000003784 fluoroethyl group Chemical group [H]C([H])(F)C([H])([H])* 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 229960005150 glycerol Drugs 0.000 description 1
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- 238000007756 gravure coating Methods 0.000 description 1
- 150000008282 halocarbons Chemical class 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 229940051250 hexylene glycol Drugs 0.000 description 1
- 239000008240 homogeneous mixture Substances 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 229940033357 isopropyl laurate Drugs 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- 229960000829 kaolin Drugs 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 229940116335 lauramide Drugs 0.000 description 1
- 229940070765 laurate Drugs 0.000 description 1
- 229940057905 laureth-3 Drugs 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 230000001050 lubricating effect Effects 0.000 description 1
- HCWCAKKEBCNQJP-UHFFFAOYSA-N magnesium orthosilicate Chemical compound [Mg+2].[Mg+2].[O-][Si]([O-])([O-])[O-] HCWCAKKEBCNQJP-UHFFFAOYSA-N 0.000 description 1
- 239000000391 magnesium silicate Substances 0.000 description 1
- 235000019792 magnesium silicate Nutrition 0.000 description 1
- 229910052919 magnesium silicate Inorganic materials 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 229960001855 mannitol Drugs 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 230000001617 migratory effect Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 229940042472 mineral oil Drugs 0.000 description 1
- 239000012184 mineral wax Substances 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- QEALYLRSRQDCRA-UHFFFAOYSA-N myristamide Chemical compound CCCCCCCCCCCCCC(N)=O QEALYLRSRQDCRA-UHFFFAOYSA-N 0.000 description 1
- 229940043348 myristyl alcohol Drugs 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- 239000004745 nonwoven fabric Substances 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000007645 offset printing Methods 0.000 description 1
- FATBGEAMYMYZAF-KTKRTIGZSA-N oleamide Chemical compound CCCCCCCC\C=C/CCCCCCCC(N)=O FATBGEAMYMYZAF-KTKRTIGZSA-N 0.000 description 1
- FATBGEAMYMYZAF-UHFFFAOYSA-N oleicacidamide-heptaglycolether Natural products CCCCCCCCC=CCCCCCCCC(N)=O FATBGEAMYMYZAF-UHFFFAOYSA-N 0.000 description 1
- 125000006353 oxyethylene group Chemical group 0.000 description 1
- 239000012785 packaging film Substances 0.000 description 1
- 229920006280 packaging film Polymers 0.000 description 1
- 229940101267 panthenol Drugs 0.000 description 1
- 235000020957 pantothenol Nutrition 0.000 description 1
- 239000011619 pantothenol Substances 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- WXZMFSXDPGVJKK-UHFFFAOYSA-N pentaerythritol Chemical compound OCC(CO)(CO)CO WXZMFSXDPGVJKK-UHFFFAOYSA-N 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- 229920000548 poly(silane) polymer Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 238000007639 printing Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
- 229960003415 propylparaben Drugs 0.000 description 1
- 239000011814 protection agent Substances 0.000 description 1
- 239000003531 protein hydrolysate Substances 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 description 1
- 238000006268 reductive amination reaction Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000000518 rheometry Methods 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 150000004671 saturated fatty acids Chemical class 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000010686 shark liver oil Substances 0.000 description 1
- 229940069764 shark liver oil Drugs 0.000 description 1
- 150000004756 silanes Chemical class 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 230000036559 skin health Effects 0.000 description 1
- APSBXTVYXVQYAB-UHFFFAOYSA-M sodium docusate Chemical compound [Na+].CCCCC(CC)COC(=O)CC(S([O-])(=O)=O)C(=O)OCC(CC)CCCC APSBXTVYXVQYAB-UHFFFAOYSA-M 0.000 description 1
- FVEFRICMTUKAML-UHFFFAOYSA-M sodium tetradecyl sulfate Chemical compound [Na+].CCCCC(CC)CCC(CC(C)C)OS([O-])(=O)=O FVEFRICMTUKAML-UHFFFAOYSA-M 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 239000012177 spermaceti Substances 0.000 description 1
- 229940084106 spermaceti Drugs 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 229940037312 stearamide Drugs 0.000 description 1
- 229940012831 stearyl alcohol Drugs 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
- 230000000475 sunscreen effect Effects 0.000 description 1
- 239000000516 sunscreening agent Substances 0.000 description 1
- 229920000247 superabsorbent polymer Polymers 0.000 description 1
- 239000004583 superabsorbent polymers (SAPs) Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 239000003760 tallow Substances 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 125000006337 tetrafluoro ethyl group Chemical group 0.000 description 1
- 125000003396 thiol group Chemical group [H]S* 0.000 description 1
- 125000003944 tolyl group Chemical group 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 235000019731 tricalcium phosphate Nutrition 0.000 description 1
- ZIBGPFATKBEMQZ-UHFFFAOYSA-N triethylene glycol Chemical compound OCCOCCOCCO ZIBGPFATKBEMQZ-UHFFFAOYSA-N 0.000 description 1
- 125000004205 trifluoroethyl group Chemical group [H]C([H])(*)C(F)(F)F 0.000 description 1
- 229940057400 trihydroxystearin Drugs 0.000 description 1
- LINXHFKHZLOLEI-UHFFFAOYSA-N trimethyl-[phenyl-bis(trimethylsilyloxy)silyl]oxysilane Chemical compound C[Si](C)(C)O[Si](O[Si](C)(C)C)(O[Si](C)(C)C)C1=CC=CC=C1 LINXHFKHZLOLEI-UHFFFAOYSA-N 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 239000004034 viscosity adjusting agent Substances 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 239000003871 white petrolatum Substances 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- MTZBBNMLMNBNJL-UHFFFAOYSA-N xipamide Chemical compound CC1=CC=CC(C)=C1NC(=O)C1=CC(S(N)(=O)=O)=C(Cl)C=C1O MTZBBNMLMNBNJL-UHFFFAOYSA-N 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 125000005023 xylyl group Chemical group 0.000 description 1
- 210000005253 yeast cell Anatomy 0.000 description 1
- 239000004246 zinc acetate Substances 0.000 description 1
- 235000013904 zinc acetate Nutrition 0.000 description 1
- 239000011667 zinc carbonate Substances 0.000 description 1
- 235000004416 zinc carbonate Nutrition 0.000 description 1
- 229910000010 zinc carbonate Inorganic materials 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- 235000014692 zinc oxide Nutrition 0.000 description 1
- XOOUIPVCVHRTMJ-UHFFFAOYSA-L zinc stearate Chemical compound [Zn+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O XOOUIPVCVHRTMJ-UHFFFAOYSA-L 0.000 description 1
- RNWHGQJWIACOKP-UHFFFAOYSA-N zinc;oxygen(2-) Chemical compound [O-2].[Zn+2] RNWHGQJWIACOKP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Absorbent Articles And Supports Therefor (AREA)
Abstract
Description
技术领域Technical field
本发明涉及一次性吸湿用品,如尿布和成年人失禁用品,本发明更具体地涉及能够有效处置尿液和低粘度粪便的一次性吸湿用品。The present invention relates to disposable absorbent articles, such as diapers and adult incontinence articles, and more particularly, to disposable absorbent articles capable of effectively disposing of urine and low viscosity feces.
背景技术 Background technique
在市场上可以买到许多种诸如尿布那样的用于吸收尿液的高容量一次性吸湿用品。这类一次性用品通常包括某种能透液的顶片材料、一个吸湿芯及一个不透液的底片材料。虽然这些类型的吸湿结构对于吸收液体来说是高效的,但它们不能吸收粪便(即,下文称为“BM”)。通常,BM截留在透液的顶片的外表面和穿用者的皮肤之间,许多粘附到穿用者的皮肤上。There are many commercially available high capacity disposable absorbent articles such as diapers for absorbing urine. Disposable articles of this type generally comprise a liquid permeable topsheet material, an absorbent core and a liquid impermeable backsheet material. While these types of absorbent structures are highly effective for absorbing liquids, they are not capable of absorbing faeces (ie, hereinafter referred to as "BM"). Typically, BM is trapped between the outer surface of the liquid permeable topsheet and the wearer's skin, and many adhere to the wearer's skin.
为了防止BM粘附到穿用者的皮肤上,在将吸湿用品放置到穿用者身体上之前,护理者常常将保护性的或“防水的”产品如凡士林或矿物油施用到臀部或肛门部位上。该步骤通常包括护理者将油或润肤液倒在其一只手上,摩擦两只手以将上述物质分布在手上,然后将该物质擦在婴儿的皮肤上。为了消除这种浪费、繁琐且易忘的步骤,现已进行了许多尝试,制备出在顶片上含有保护性的或治疗用的护肤物质的吸湿用品。To prevent BM from sticking to the wearer's skin, caregivers often apply protective or "waterproof" products such as petrolatum or mineral oil to the buttocks or anal area before placing the absorbent article on the wearer's body superior. This procedure usually involves the caregiver pouring an oil or lotion on one of her hands, rubbing both hands to distribute the substance over the hands, and then rubbing the substance on the baby's skin. In order to eliminate this wasteful, tedious and forgettable step, many attempts have been made to produce absorbent articles containing protective or therapeutic skin care substances on the topsheet.
一种已经作为润肤液施用到吸湿产品上以赋予柔软、保护性涂层的物质是矿物油。矿物油(也称为液体矿脂)是通过蒸馏石油中的高沸点(即,300-390℃)馏分而得到的各种液体烃的混合物。矿物油在环境温度如20-25℃是液体。结果,矿物油相对上是流体和流动的,即使当施用到用品的顶片上时,也是如此。One substance that has been applied to absorbent products as a lotion to impart a soft, protective coating is mineral oil. Mineral oil (also known as liquid petrolatum) is a mixture of various liquid hydrocarbons obtained by distillation of the high boiling (ie, 300-390° C.) fraction of petroleum. Mineral oil is liquid at ambient temperature, eg 20-25°C. As a result, mineral oils are relatively fluid and runny, even when applied to the topsheet of an article.
由于矿物油在环境温度下是流体状和流动的,其往往不能保持固定在顶片的表面上,相反其通过顶片迁移进入尿布的内部。因此,需要向顶片上施用相对高用量的矿物油以提供所需的治疗或保护性涂层的润肤好处。这不仅增加这些加有润肤液的产品的成本,而且还有其它有害的影响。Since mineral oil is fluid and mobile at ambient temperature, it tends not to remain fixed on the surface of the topsheet, instead it migrates through the topsheet into the interior of the diaper. Accordingly, relatively high levels of mineral oil need to be applied to the topsheet to provide the desired emolliency benefit of the therapeutic or protective coating. Not only does this increase the cost of these lotioned products, but it also has other deleterious effects.
这些有害影响之一是流体处理性能的降低,因为高含量的矿物油往往堵塞顶片的开口。而且,当矿物油迁移到用品的内部时,其往往用作疏水添加剂,因此降低下层吸湿芯的吸湿性,如果使用一种用品的话。当所施用的矿物油的量增加时,吸湿性的降低将更加明显。One of these detrimental effects is a reduction in fluid handling performance, since high levels of mineral oil tend to clog the openings of the topsheet. Also, when mineral oil migrates to the interior of the article, it tends to act as a hydrophobic additive, thereby reducing the absorbency of the underlying absorbent core, if an article is used. The reduction in hygroscopicity will be more pronounced as the amount of mineral oil applied increases.
即使不增加其用量,施用后矿物油的迁移趋势也具有其它有害影响。例如,所施加的矿物油可以迁移到、进入并通过加有润肤液的产品的包装材料。这可能需要屏障型包装薄膜避免产品中矿物油弄胀或其它泄漏。The tendency of mineral oils to migrate after application has other detrimental effects even without increasing their levels. For example, applied mineral oil can migrate to, into, and through the packaging material of a moisturizer-laden product. This may require barrier packaging films to prevent swelling or other leakage of mineral oil in the product.
为了克服与矿物油相关的问题,已经将润肤液施用到吸湿产品上。加有润肤液的吸湿产品:(1)具有治疗或保护性好处,(2)不需要在室温下是液体的相当高含量的涂层(如,矿物油);和(3)包装中不需要特殊的包装或阻挡材料。In order to overcome the problems associated with mineral oil, lotions have been applied to absorbent products. Hygroscopic products with lotion: (1) have therapeutic or protective benefits, (2) do not require a relatively high level of coating (e.g., mineral oil) that is liquid at room temperature; and (3) contain no Requires special packaging or barrier material.
尽管加有润肤液的吸湿产品确实解决了与矿物油相关的问题,但在将润肤液施用到吸湿产品上时必须小心以防止顶片的闭塞。先前的顶片的这类闭塞防止尿液渗透通过顶片,不可避免地导致泄漏。为了克服该问题,已经将润肤液以不会涂布顶片的整个表面上的方式施加到顶片上,从而使顶片的某些部分不含润肤液。这类涂布技术的一个实例是以彼此隔开的条状施用润肤液。尽管润肤液条确实使尿液渗透过顶片,但增加了施加方法的复杂性,可能会使润肤液不均匀地输送到皮肤上并可能会使顶片的未处理区域被污染,从而减少了尿液转移到下层的吸湿元件。While lotioned absorbent products do solve the problems associated with mineral oil, care must be taken when applying lotions to absorbent products to prevent occlusion of the topsheet. This type of occlusion of previous topsheets prevents urine from penetrating through the topsheet, inevitably leading to leakage. To overcome this problem, lotions have been applied to the topsheet in a manner that does not coat the entire surface of the topsheet, thereby leaving certain portions of the topsheet free of lotion. An example of such an application technique is to apply the lotion in spaced apart strips. While lotion strips do allow urine to penetrate through the topsheet, they add to the complexity of the application method, may allow the lotion to be delivered unevenly to the skin and may contaminate untreated areas of the topsheet, thereby Absorbent elements that reduce the transfer of urine to the underlying layer.
因此,本发明的一个目的是提供具有结构化的载体的一次性吸湿用品,所述载体具有优异的尿液和BM处置性能。这里所用的术语“结构化的载体”指任何二维或三维的形态结构,设计该结构来携带然后输送一种组合物,同时仍保持尿液可在其中通过的通道。It is therefore an object of the present invention to provide disposable absorbent articles having a structured carrier having excellent urine and BM disposal properties. As used herein, the term "structured carrier" refers to any two-dimensional or three-dimensional morphological structure designed to carry and then deliver a composition while still maintaining a pathway through which urine can pass.
本发明的另一个目的是提供一次性吸湿用品用的一种结构化的载体,该载体具有有效开孔面积和多个开孔,该开孔具有充分的有效尺寸以使尿液和低粘度粪便在其中渗透通过以致于可以相对容易地施用护肤组合物,同时消除了结构化的载体的闭塞问题。这里所用的术语“护肤组合物”指含有一种或多种试剂的任何组合物,当从用品转移到穿用者的皮肤上时,该组合物可提供治疗和/或保护皮肤的好处。下面将详细讨论示范性的材料。Another object of the present invention is to provide a structured carrier for disposable absorbent articles having an effective open area and a plurality of open cells of sufficient effective size to allow urine and low-viscosity feces to Permeation through allows for relatively easy application of skin care compositions while eliminating occlusion problems with structured carriers. As used herein, the term "skin care composition" refers to any composition containing one or more agents which, when transferred from the article to the skin of the wearer, provide therapeutic and/or protective benefits to the skin. Exemplary materials are discussed in detail below.
本发明的另一个优点是提供在结构化的载体的外表面上具有护肤组合物的吸湿用品,该组合物可转移到穿用者的皮肤上且其有效地产生所需的皮肤好处和/或减少BM粘附到皮肤上,从而改进BM的易清洁性,同时不会抑制结构化的载体处置尿液的能力。Another advantage of the present invention is to provide an absorbent article having a skin care composition on the outer surface of the structured carrier that is transferable to the skin of the wearer and that is effective to produce the desired skin benefits and/or Reduces the adhesion of BM to the skin, thereby improving the ease of cleaning of BM without inhibiting the ability of the structured carrier to dispose of urine.
使用本发明可得到这些和其它目的,通过阅读下列公开内容将对本发明更清楚。These and other objects are attainable by use of the present invention, which will become more apparent upon reading the following disclosure.
发明内容Contents of Invention
本发明是一次性吸湿用品如尿布。该一次性吸湿用品含有结构化的载体、至少部分周边连接到结构化的载体上的不透液的底片和位于结构化的载体和底片之间的吸湿芯。当穿用该一次性吸湿用品时,该结构化的载体具有朝向一次性吸湿用品的内部取向的内表面和朝向穿用者的皮肤取向的外表面。该结构化的载体具有至少约12%的有效开孔面积和许多有效尺寸大于0.1平方毫米的孔。该结构化的载体的外表面含有有效量的护肤组合物,该组合物在20℃下是半固体或固体的,且其可部分转移到穿用者的皮肤上。The present invention is a disposable absorbent article such as a diaper. The disposable absorbent article comprises a structured carrier, a liquid impermeable backsheet at least partially peripherally attached to the structured carrier, and an absorbent core positioned between the structured carrier and the backsheet. The structured carrier has an inner surface oriented towards the interior of the disposable absorbent article and an outer surface oriented towards the skin of the wearer when the disposable absorbent article is worn. The structured support has an effective open pore area of at least about 12% and a plurality of pores with an effective size greater than 0.1 square millimeters. The outer surface of the structured carrier contains an effective amount of a skin care composition which is semi-solid or solid at 20°C and which is partially transferable to the skin of the wearer.
附图说明Description of drawings
尽管本说明书以指出并明确要求保护本发明的权利要求书结束,但认为,通过下列附图并结合所附的说明将更好地理解本发明,其中相同的部件以相同的标号给出,其中Although the specification concludes with claims pointing out and distinctly claiming the invention, it is believed that the invention will be better understood from the following drawings when read in conjunction with the accompanying description, wherein like parts have been given like numerals, wherein
图1是以部分剖视图示出的本发明的一次性吸湿用品的俯视图。BRIEF DESCRIPTION OF THE DRAWINGS Figure 1 is a plan view of the disposable absorbent article of the present invention, shown in partial cross-section.
具体实施方式 Detailed ways
这里所用“吸湿用品”一词是指一个吸收并保存身体排出物的用品,更具体地说,指贴近或靠近穿用者的身体放置以吸收且存留从身体排出的各种排泄物的用品。“一次性”一词是说明不打算洗涤或以其它方式复原或作为吸湿用品再使用的吸湿用品(即,在使用一次后往往被抛弃且优选被循环、制成堆肥或以适合环保的其它方式进行处理)。“整体的”吸湿用品指由独立的部件结合在一起而形成协调的整体以便它们不需要独立的操作部件如独立的套和衬的吸湿用品。本发明吸湿用品的优选实施方案是整体的一次性吸湿用品,如图1所示的尿布20。本发明所用的术语“尿布”指通常由婴儿和成人失禁者佩戴在其下躯周围的吸湿用品。本发明也适用于其它吸湿用品如失禁短裤、失禁内衣、吸湿垫、尿布套和衬里、妇女卫生衣服等。The term "absorbent article" as used herein means an article which absorbs and retains body exudates, and more particularly, an article which is placed against or near the body of the wearer to absorb and retain various exudates discharged from the body. The term "disposable" is used to describe absorbent articles that are not intended to be laundered or otherwise restored or reused as an absorbent article (i.e., tend to be discarded after one use and are preferably recycled, composted, or otherwise disposed of in an environmentally appropriate manner) be processed). "Unity"absorbent articles are absorbent articles that are composed of separate parts joined together to form a coherent whole so that they do not require separate operating parts such as separate casings and liners. A preferred embodiment of the absorbent article of the present invention is a unitary disposable absorbent article, such as the diaper 20 shown in FIG. As used herein, the term "diaper" refers to an absorbent article typically worn by infants and adult incontinent persons around their lower torso. The present invention is also applicable to other absorbent articles such as incontinence pants, incontinence underwear, absorbent pads, diaper covers and liners, feminine hygiene garments, and the like.
图1是本发明的尿布20呈其展平的、未收缩的状态的平面图(即,拉出弹性引起的收缩),其中部分结构剖去以更清楚地示出尿布20的构造,其中朝向且接触穿用者的尿布20部分,即内表面朝向观察者。如图1所示,尿布20优选包括一透液的结构化的载体24、与该结构化的载体24相连的不透液的底片26和位于该结构化的载体24和底片26之间的吸湿芯28。尿布20可进一步包括弹性线制的侧片(未示出)、弹性线制的腿部收口(未示出)、弹性腰部件(未示出)和具有胶带片(tape tabs)的紧固体系,多处一般都用36表示。Figure 1 is a plan view of the diaper 20 of the present invention in its flattened, uncontracted state (i.e., pulled out of the contraction caused by the elastic), with portions cut away to more clearly show the construction of the diaper 20, wherein towards and The portion of the diaper 20 that contacts the wearer, ie, the inner surface, faces the viewer. As shown in Figure 1, the diaper 20 preferably comprises a liquid permeable structured carrier 24, a liquid impermeable backsheet 26 attached to the structured carrier 24, and an absorbent absorbent material positioned between the structured carrier 24 and the backsheet 26. Core 28. The diaper 20 may further include elasticized side panels (not shown), elasticated leg cuffs (not shown), elastic waist features (not shown) and a fastening system with tape tabs , and many places are generally represented by 36.
示于图1的尿布20具有第一腰区27、第二腰区29、位于第一腰区27和第二腰区29之间的裆区31和由尿布20的外边缘限定的周边,当穿用该尿布20时,第一腰区27与穿用者的前部并置,第二腰区29与第一腰区27相对且与穿用者的后部并置,其中尿布的纵边标为33,端边标为35。尿布20的内表面包括使用期间与穿用者的身体相邻的尿布20部分(即,内表面通常由至少一部分结构化的载体24和与该结构化的载体24相连的其它部件构成)。外表面包括使用期间远离穿用者的身体放置的尿布20部分(即,外表面通常由至少一部分底片26和与该底片26相连的其它部件构成)。The diaper 20 shown in Figure 1 has a first waist region 27, a second waist region 29, a crotch region 31 between the first waist region 27 and the second waist region 29 and a perimeter defined by the outer edge of the diaper 20, when When wearing this diaper 20, the first waist region 27 is juxtaposed with the front of the wearer, and the second waist region 29 is opposite to the first waist region 27 and juxtaposed with the back of the wearer, wherein the longitudinal sides of the diaper Marked as 33, end marked as 35. The interior surface of the diaper 20 includes the portion of the diaper 20 that is adjacent to the wearer's body during use (ie, the interior surface is typically comprised of at least a portion of the structured carrier 24 and other components associated with the structured carrier 24). The outer surface comprises the portion of the diaper 20 that is positioned away from the wearer's body during use (ie, the outer surface is typically formed from at least a portion of the backsheet 26 and other components associated with the backsheet 26).
图1表示尿布20的一实施方案,其中结构化的载体24和底片26的长度和宽度尺寸通常大于吸湿芯的长度和宽度尺寸。结构化的载体24和底片26延伸超出吸湿芯28的边缘,从而形成尿布20的周边。尽管结构化的载体24、底片26和吸湿芯28可以以多种公知的构型组装,但优选的尿布构型通常描述于下列文献中:1975年1月14日授予Kenneth B.Buell的USP3,860,003,题目为“一次性尿布的可收缩的侧部”;1992年9月29日授予Kenneth B.Buell等人的USP5,151,092,题目为“具有预先设置的弹性挠性铰接的动态弹性腰部件的吸湿用品”;将上述两个专利引入本发明作为参考。Figure 1 shows an embodiment of a diaper 20 in which the structured carrier 24 and backsheet 26 have length and width dimensions generally greater than the length and width dimensions of the absorbent core. The structured carrier 24 and backsheet 26 extend beyond the edges of the absorbent core 28 to form the perimeter of the diaper 20 . Although the structured carrier 24, backsheet 26 and absorbent core 28 can be assembled in a variety of well-known configurations, preferred diaper configurations are generally described in USP 3, issued January 14, 1975 to Kenneth B. Buell, 860,003, entitled "Contractible Sides of Disposable Diapers"; USP 5,151,092, issued September 29, 1992 to Kenneth B. Buell et al., entitled "Dynamic Elastic Waist Member with Preset Elastic Flexure Hinges" absorbent article"; the above two patents are incorporated herein by reference.
吸湿芯28可以是通常可压缩的、贴合的以及对穿用者的皮肤无刺激的且能够吸收并保存液体如尿液和其它身体排出物的任何吸湿件。如图1所示,吸湿芯28具有衣物面、身体面、侧边和腰边。吸湿芯28可制成多种不同的尺寸和形状(例如矩形、沙漏形、T形、不对称形等),并可由多种通常用于一次性尿布和其它吸湿用品的吸收液体的材料制成,如通常称为空气毡的粉碎木浆。其它适合的吸湿材料的例子包括起皱的纤维素填料;包括共成(coform)的熔喷聚合物;化学硬挺、改性或交联的纤维素纤维;薄纸,包括薄纸包裹物和层压薄纸;吸湿泡沫;吸湿海绵;超吸湿聚合物;吸湿凝胶材料或任何等效的材料或材料的组合。The absorbent core 28 can be any absorbent member that is generally compressible, conformable and non-irritating to the wearer's skin and capable of absorbing and retaining liquids such as urine and other body exudates. As shown in Figure 1, the absorbent core 28 has a garment side, a body side, side edges and a waist edge. The absorbent core 28 can be made in many different sizes and shapes (e.g., rectangular, hourglass, T-shaped, asymmetrical, etc.), and can be made of a variety of liquid-absorbent materials commonly used in disposable diapers and other absorbent articles. , such as comminuted wood pulp commonly known as airfelt. Examples of other suitable absorbent materials include creped cellulose wadding; melt blown polymers including coform; chemically stiffened, modified or crosslinked cellulose fibers; tissues, including tissue wraps and layers Pressed paper; absorbent foam; absorbent sponge; superabsorbent polymers; absorbent gelling material or any equivalent material or combination of materials.
吸湿芯28的构形和构造也可以是各种各样的(例如,吸湿芯28可以具有各种厚度区、亲水梯度、超吸湿梯度、较低平均密度及较低平均定量区;或可包括一层或多层或一种或多种结构)。但是,吸湿芯28的总吸收容量应该与尿布20的设计负荷和预期用途相一致。此外,吸湿芯28的尺寸和吸收容量可以是多种多样的以适合从婴儿到成年人的穿用者。The configuration and configuration of the absorbent core 28 can also be varied (for example, the absorbent core 28 can have zones of various thicknesses, gradients of hydrophilicity, gradients of superabsorbency, lower average density, and lower average basis weight zones; or can have Including one or more layers or one or more structures). However, the total absorbent capacity of the absorbent core 28 should be consistent with the design load and intended use of the diaper 20. In addition, the size and absorbent capacity of the absorbent core 28 can be varied to suit wearers from infants to adults.
用作吸湿芯28的典型的吸湿结构在1986.9.9授予Weisman等人、题为“高密度吸湿结构”的美国专利4,610,678;1987.6.16授予Weisman等人、题为“具有双层芯的吸湿用品”的美国专利4,673,402;1989.12.19授予Angstadt题为“具有打底层的吸湿芯”的美国专利4,888,231;1989.5.30授予Alemany等人题为“具有低密度和低定量收集区的高密度吸湿件”的美国专利4,834,735中进行了描述,将这些专利引入本发明作为参考。Typical absorbent structures used as the absorbent core 28 were granted to Weisman et al., US Patent 4,610,678 entitled "High Density Absorbent Structure" on September 9, 1986; "U.S. Patent 4,673,402; 1989.12.19 granted to Angstadt entitled "Absorbent Core with a Backing Layer" US Patent 4,888,231; 1989.5.30 granted to Alemany et al. entitled "High Density Absorbent with Low Density and Low Weight Acquisition Area" described in US Patent 4,834,735, which is incorporated herein by reference.
底片26邻近吸湿芯28的衣物面放置,且优选通过固定件(未示出)如本领域公知的那些固定件连接到吸湿芯上。本发明所用的术语“连接”包括下列构型:其中通过将一个元件直接固定到另一个元件上而将该元件直接固定到其它元件上,以及通过将一个元件先固定到中间元件上,该中间元件又固定到其它元件上而将一元件间接固定到其它元件上。The backsheet 26 is positioned adjacent the garment side of the absorbent core 28 and is preferably attached to the absorbent core by fasteners (not shown) such as those known in the art. The term "attached" as used in the present invention includes configurations in which one element is fixed directly to another element by fixing the element directly to the other element, as well as by first fixing an element to an intermediate element, the intermediate Components are in turn fixed to other components and one component is indirectly fixed to other components.
例如,底片26可以通过均匀连续的粘结剂层、构图的粘结剂层或粘结剂的分离的线、螺旋线或点的排列而固定到吸湿芯28上。已经发现令人满意的粘接剂为H.B.Fuller Company of St.Paul,Minnesota生产,代号为HL-1258的产品。连接手段优选包括例如1986.3.4授予Minetola等人的题为“一次性废物-保持衣物”的美国专利4,573,986中所述的粘接剂细丝的开口图案网络,更优选是几条盘绕成螺旋图案的粘接剂细丝线,如1975.10.7授予Sprague,Jr.的美国专利3,911,173;1978.11.22授予Ziecker等人的美国专利4,785,996;1989.6.27授予Werenicz的美国专利4,842,666中所示的设备及方法所图示。这里引入以上各项专利作为参考。另一方面,连接手段可包括热粘接、压力粘接、超声粘接、动态机械粘接、或如本领域公知的任何其它适用的粘接手段、或这些手段的组合。For example, the backsheet 26 may be secured to the absorbent core 28 by a uniform continuous layer of adhesive, a patterned layer of adhesive, or an array of discrete lines, spirals, or spots of adhesive. A satisfactory adhesive has been found to be that manufactured by H.B. Fuller Company of St. Paul, Minnesota, under the designation HL-1258. The attachment means preferably comprises an open pattern network of adhesive filaments, more preferably several coiled in a helical pattern, such as described in U.S. Patent 4,573,986, entitled "Disposable Waste - Retaining Garment" issued March 4, 1986 to Minetola et al. Adhesive filament thread, such as 1975.10.7 to Sprague, Jr.'s US Patent 3,911,173; 1978.11.22 to Ziecker et al. US Patent 4,785,996; 1989.6.27 to Werenicz's US Patent 4,842,666 shown in the device and method icon. The above patents are incorporated herein by reference. In another aspect, attachment means may include thermal bonding, pressure bonding, ultrasonic bonding, dynamic mechanical bonding, or any other suitable bonding means as known in the art, or a combination of these means.
底片26对液体如尿液是不可透的并优选由一塑料薄膜制成,虽然也可以使用其它柔性的不透液材料。这里所用“柔性的”一词是指材料是柔顺的并将容易地与人体的大致形状及轮廓相一致。The backsheet 26 is impermeable to liquids, such as urine, and is preferably made of a plastic film, although other flexible liquid impermeable materials may also be used. The term "flexible" as used herein means that the material is compliant and will readily conform to the general shape and contours of the human body.
底片26防止吸湿芯28中吸收并保存的排出物弄湿接触尿布20的物品如床单和内衣。因此,底片26可能包括一种纺织或无纺材料;诸如聚乙烯或聚丙烯热塑薄膜那样的聚合物薄膜;或诸如一种镀膜的无纺材料那样的复合材料。优选,底片26是厚度为约0.012mm(0.5mil)到约0.051mm(2.0mils)的热塑薄膜。底片26所用的特别优选的材料包括由Tredegar Industuies,Inc.(Terre Haute,Indiana)制造的RR8220吹制薄膜和RR5475铸膜。底片26优选为压花的和/或经过消光处理的以提供一个更似织物的外观。另外,在仍防止排泄物通过底片26的同时,底片26可允许蒸汽从吸湿芯28逸出(即,透气的)。The backsheet 26 prevents exudates absorbed and contained in the absorbent core 28 from wetting articles that contact the diaper 20, such as bed sheets and undergarments. Thus, the backsheet 26 may comprise a woven or nonwoven material; a polymeric film such as a polyethylene or polypropylene thermoplastic film; or a composite material such as a coated nonwoven material. Preferably, the backsheet 26 is a thermoplastic film having a thickness of about 0.012 mm (0.5 mil) to about 0.051 mm (2.0 mils). Particularly preferred materials for the backsheet 26 include RR8220 blown film and RR5475 cast film manufactured by Tredegar Industries, Inc. (Terre Haute, Indiana). The backsheet 26 is preferably embossed and/or matte finished to provide a more textile-like appearance. Additionally, the backsheet 26 may allow vapors to escape from the absorbent core 28 (ie, be breathable) while still preventing exudates from passing through the backsheet 26 .
当穿用尿布时,结构化的载体24具有朝向一次性尿布的内部取向、特别是朝向吸湿芯28取向的第一或内表面,和朝向穿用者的皮肤取向的相对的第二或外表面。The structured carrier 24 has a first or inner surface oriented towards the interior of the disposable diaper, particularly the absorbent core 28, and an opposite second or outer surface oriented towards the wearer's skin when the diaper is worn. .
结构化的载体24与吸湿芯28的身体面并置,但不必与其相邻,且优选通过本领域公知的连接手段连接到底片26或吸湿芯28上。合适的连接手段是上述针对将底片26连接到吸湿芯28的那些。在本发明的优选实施方案中,结构化的载体24和底片26在尿布周边彼此直接相连。The structured carrier 24 is juxtaposed with, but not necessarily adjacent to, the body surface of the absorbent core 28, and is preferably attached to the backsheet 26 or the absorbent core 28 by attachment means known in the art. Suitable attachment means are those described above for attaching the backsheet 26 to the absorbent core 28 . In a preferred embodiment of the present invention, the structured carrier 24 and the backsheet 26 are directly attached to each other at the periphery of the diaper.
结构化的载体24是柔顺的、柔软感的且对穿用者的皮肤无刺激性。而且,结构化的载体24是透液的、允许液体(如尿液)容易透过其厚度。合适的结构化的载体24可由许多材料制成,如多孔泡沫、网状泡沫、带孔的塑料薄膜,或天然纤维(如木或棉纤维)、合成纤维(如聚酯或聚丙烯纤维)或天然和合成纤维组合的纺织或无纺网面。优选的是,结构化的载体24由疏水性材料制成以将穿用者的皮肤与吸湿芯28中所含的液体隔离开。另一方面,结构化的载体24可以用表面活性剂进行处理以使其成为亲水性的。The structured carrier 24 is compliant, soft feeling and non-irritating to the wearer's skin. Furthermore, the structured carrier 24 is liquid permeable, allowing liquids, such as urine, to readily pass through its thickness. A suitable structured carrier 24 can be made of many materials, such as porous foam, reticulated foam, perforated plastic film, or natural fibers (such as wood or cotton fibers), synthetic fibers (such as polyester or polypropylene fibers) or Woven or nonwoven webs with a combination of natural and synthetic fibers. Preferably, the structured carrier 24 is made of a hydrophobic material to isolate the wearer's skin from liquids contained in the absorbent core 28 . Alternatively, structured carrier 24 can be treated with a surfactant to render it hydrophilic.
结构化的载体24优选具有多个孔,该多个孔的有效尺寸至少为0.2平方毫米、更优选至少为0.5平方毫米、进一步优选至少为1.0平方毫米、最优选至少为2.0平方毫米。有效孔是在下文描述的图像采集参数下,在标准灰度级刻度0-255上的灰度级为18或更低的那些。Structured support 24 preferably has a plurality of pores having an effective size of at least 0.2 square millimeters, more preferably at least 0.5 square millimeters, still more preferably at least 1.0 square millimeters, most preferably at least 2.0 square millimeters. Valid wells are those with a gray level of 18 or lower on a standard gray scale scale of 0-255 under the image acquisition parameters described below.
结构化的载体24优选的有效开孔面积至少15%、更优选至少为20%、进一步优选至少25%、最优选至少为30%。The structured carrier 24 preferably has an active open area of at least 15%, more preferably at least 20%, further preferably at least 25%, most preferably at least 30%.
采用下文的图像分析通过下列程序测定有效孔尺寸和有效开孔面积。该程序具有三个主要步骤:图像采集,即获得结构化的载体24的表面上区域的代表性的图像;图像测量,即,测量图像的开孔面积百分数和各个孔的面积以及它们的周长;和数据分析,即将开孔面积百分数、各个孔的面积和周长测量值输出到一个扩展表(spreadsheet),在该扩展表中进行频率分布、面积分布的和以及水力半径的计算。Effective pore size and effective open pore area were determined by the following procedure using the image analysis below. The procedure has three main steps: image acquisition, i.e. obtaining a representative image of the area on the surface of the structured support 24; image measurement, i.e. measuring the image for the percent open area and the area of the individual pores and their perimeter and data analysis, outputting the percent open area, area and perimeter measurements of individual holes to a spreadsheet where frequency distribution, sum of area distributions, and hydraulic radius calculations are performed.
使用具有帧接收器板(frame grabberboard)、显微镜、摄像机和图像分析软件的图像分析系统。提供一DT2855型帧接收器板,购自DataTranslation(Marlboro,Mass.)。还提供一VH5900监控显微镜、视频摄像机,其具有接触型照射头的VH50镜头,购自Keyence Company(Fair Lawn,N.J.),用于采集图像并将图像存储到计算机文件中。Keyence显微镜采集图像,而帧接收器板将该图像的模拟信号转换为计算机可读的数字格式。将图像存储到计算机文件中,并使用合适的软件如购自BioScan Company(Edmaons,Wash.)的Optimas Image Analysis软件,3.1版本进行测量。为了使用Optimas Image Analysis软件,计算机应具有购自微软公司(Redmond,Wash.)的Windows软件,3.0或更高的版本。还应具有至少相当于Intel 80386的CPU。可以使用任何合适的台式PC机,现已经发现486DX33型PC机是特别适合的。在Sony Trinitron监控器型号为PVM-1343MO上以最终显示放大倍数为约50倍显示存储到文件中并从文件中调出的图像。An image analysis system with a frame grabber board, microscope, video camera and image analysis software is used. A frame grabber board, model DT2855, available from DataTranslation (Marlboro, Mass.) was provided. A VH5900 surveillance microscope, video camera with a VH50 lens with a contact head, available from Keyence Company (Fair Lawn, N.J.), was also provided to acquire images and store the images to a computer file. The Keyence microscope acquires the image, and the frame grabber board converts the analog signal of that image into a computer-readable digital format. Images are stored to a computer file and measurements are made using suitable software such as Optimas Image Analysis software, version 3.1, available from BioScan Company (Edmaons, Wash.). In order to use the Optimas Image Analysis software, the computer should have Windows software, version 3.0 or higher, available from Microsoft Corporation (Redmond, Wash.). Should also have a CPU at least equivalent to an Intel 80386. Any suitable desktop PC can be used and the 486DX33 model PC has been found to be particularly suitable. Images stored to and recalled from file were displayed on a Sony Trinitron monitor model PVM-1343MO at a final display magnification of approximately 50x.
上面指出的图像采集步骤需要来自特殊类型尿布20的代表性的结构化载体24样品或来自将要测试的样品材料的10个不同区域。每个区域是约5.8毫米×4.2毫米的矩形。将样品放置在黑垫板上以增加孔和限定孔的样品部分之间的对比度。黑垫板的平均灰度级和标准偏差分别为16和4。The image acquisition procedure indicated above requires a representative structured carrier 24 sample from a particular type of diaper 20 or from 10 different areas of the sample material to be tested. Each area is a rectangle of approximately 5.8 mm x 4.2 mm. Place the sample on a black backing plate to increase the contrast between the well and the portion of the sample that defines the well. The average gray level and standard deviation of the black mat were 16 and 4, respectively.
使用直接安装在样品上方的拷贝架(copystand)上的Keyence监控显微镜,将房间的灯关掉来采集图像。用Optimas软件调整并监控照射样品的Keyence光源以测量购自Eastman Kodak公司(Rochester,New York)的KodakGray Scale上黑度为0.3的光劈的平均灰度级和标准偏差。调整Keyence光源的控制机构从而照射的光劈的平均灰度级是111±1,标准偏差是10±1。在单一的时间段采集所有图像,通过在整个图像采集过程中测量光劈的平均灰度级和标准偏差来监控Keyence光源。Images were acquired with the room lights off using a Keyence monitor microscope mounted on a copystand directly above the sample. The Keyence light source that irradiated the sample was adjusted and monitored with Optimas software to measure the average gray level and standard deviation of a light split with a blackness of 0.3 on a Kodak Gray Scale purchased from Eastman Kodak Company (Rochester, New York). Adjust the control mechanism of the Keyence light source so that the average gray level of the irradiated light splitter is 111±1, and the standard deviation is 10±1. All images were acquired in a single time period, and the Keyence light source was monitored by measuring the average gray level and standard deviation of the beam splitter throughout the image acquisition.
在测量单个孔时,只有有效孔尺寸是重要的。测量有效孔尺寸对预期将对结构化的载体24的孔隙有贡献的孔尺寸进行了定量,并对横过一个预期是孔的区域的纤维和纤维束的贡献进行了说明。一个有效孔是通过结构化的载体24的、使用本文所述的图像采集参数灰度级小于或等于18的任何孔。因此,预期的孔可以被横向纤维分成多个有效的孔。When measuring individual holes, only the effective hole size is important. Measuring the effective pore size quantifies the pore size that is expected to contribute to the porosity of the structured support 24 and accounts for the contribution of fibers and fiber bundles across an area expected to be pores. A valid aperture is any aperture through structured support 24 that has a gray level of less than or equal to 18 using the image acquisition parameters described herein. Thus, a desired hole can be divided into a plurality of effective holes by the transverse fibers.
通过从样品图像获取的尺标图像以毫米来校准图像分析软件。将Optimas 3.1图像菜单中的3×3象素(pixel)的均值滤波器(averaging filter)施用于每个存储的图像以降低噪音。检测的孔灰度级范围是0-18。认为未完全包含在5.8×4.2观察区内的孔不在各个面积和周长测量值内。因此,面积和周长的平均值和分布不受未完全包含在观察区内的孔的影响。Calibrate the image analysis software in millimeters by the scale image acquired from the sample image. A 3×3 pixel averaging filter from the Optimas 3.1 Image menu was applied to each stored image to reduce noise. The detected hole gray scale range is 0-18. Holes not completely contained within the 5.8 x 4.2 viewing area were considered excluded from the respective area and perimeter measurements. Therefore, the mean values and distributions of area and perimeter are not affected by holes not completely contained within the viewing area.
但是,开孔面积百分数的计算中将包括不能被完全观察的图像中的各个孔。存在该差异是由于开孔面积百分数仅是图像内具有0-18灰度级的象素数与象素总数的比值的图象。在开孔面积的计算中不包括灰度级为19或更大的区域。However, individual holes in the image that cannot be fully observed will be included in the calculation of percent open area. This difference exists because the percent open area is simply the ratio of the number of pixels to the total number of pixels within the image with gray levels 0-18. Areas with a gray scale of 19 or greater are not included in the calculation of open area.
使用Optimas Image Analysis软件来测量每个结构化的载体24的10个图像的开孔面积百分数的平均值。开孔面积百分数定义为图像中灰度级为0-18的象素数目与象素总数的比例。测量每个代表结构化的载体样品的一个特殊区域的图像的开孔面积百分数。然后,将10个图像中每一个的开孔面积百分数加以平均以获得整个样品的开孔面积百分数。Optimas Image Analysis software was used to measure the average of the percent open area of 10 images of each structured support 24 . The percentage of open area is defined as the ratio of the number of pixels with a gray level of 0-18 to the total number of pixels in the image. The percent open area is measured for each image representing a particular region of the structured support sample. The percent open area for each of the 10 images was then averaged to obtain the percent open area for the entire sample.
通过也购自微软公司(Redmond,Wash.)的Excel扩展表(spreadsheet)来进行数据分析。Excel扩展表将得自Optimas软件的开孔面积百分数、孔面积和孔周长的测量值组织在一起。使用该扩展表获得各个孔面积的样品平均值和标准偏差、尺寸和频率分布以及各个孔的水力半径计算值(面积除以周长)。Data analysis was performed by an Excel spreadsheet, also purchased from Microsoft Corporation (Redmond, Wash.). The Excel extension table organizes the measurements of percent open cell area, cell area, and cell perimeter obtained from the Optimas software. The sample mean and standard deviation for each pore area, size and frequency distribution, and the calculated hydraulic radius (area divided by perimeter) for each pore were obtained using this expanded table.
使用Excel扩展表也计算出单个孔面积的分布。将这些孔归类成具有某些尺寸范围的库。测定落入某些目的尺寸范围内的孔面积的数目和在每个范围内的面积的和。以0.05平方毫米的增量来设置范围。将这些面积表示成样品的总开孔面积的百分数。通过组合每个样品的所有10个图像的各个孔的测量值来得到面积分布的频率和总和。The distribution of individual pore areas was also calculated using an Excel spreadsheet. The holes are sorted into libraries with certain size ranges. The number of pore areas falling within certain size ranges of interest and the sum of the areas within each range are determined. Set the range in increments of 0.05 mm². These areas are expressed as a percentage of the total open area of the samples. The frequency and sum of the area distributions were obtained by combining the individual well measurements from all 10 images for each sample.
有许多生产技术可用来生产结构化的载体24。例如,结构化的载体24可以是纺粘、梳理、湿法成网、熔喷、水力缠结、上述的组合或复合层压物等纤维的无纺网面。优选的结构化的载体24包括梳理的/梳理的复合材料和纤维网的水力缠结物,所述复合材料在成形网上水力缠结并通过无纺布领域公知的手段进行热空气穿透粘结。另一方面,有孔的成形薄膜、织造物编结网和织造物开孔编结网(woven apertured netting)也是合适的。A number of production techniques are available to produce structured vectors24. For example, structured carrier 24 may be a nonwoven web of fibers such as spunbond, carded, wetlaid, meltblown, hydroentangled, combinations of the foregoing, or composite laminates. A preferred structured carrier 24 comprises a carded/carded composite material and a hydroentangled fibrous web that is hydroentangled on a forming wire and through-air bonded by means well known in the nonwovens art. . On the other hand, apertured formed films, woven meshes and woven apertured nettings are also suitable.
尽管根据本发明的方法输送的具体组合物(下文称为“护肤组合物”和“组合物”)不是改进吸湿用品下面的区域的皮肤状况的重要因素,但是,很明显的是该组合物必须提供保护性的、非闭塞性的功能(如一相对不透液但是透蒸汽的屏障)以防止皮肤过度水合,并防止皮肤暴露在身体排泄物中所含的物质中,或者它必须含有直接或间接提供护肤功效的试剂。例如,间接功效包括改进皮肤刺激物如粪便或尿液的去除。该组合物可以呈多种形式,包括(但不限于)乳液、润肤液、乳膏、软膏、药膏、粉剂、悬浮剂、胶囊剂、凝胶等。Although the specific composition delivered according to the method of the present invention (hereinafter referred to as "skin care composition" and "composition") is not an important factor in improving the skin condition of the area below the absorbent article, it is clear that the composition must Provides a protective, non-occlusive function (such as a relatively liquid-impermeable but vapor-permeable barrier) to prevent overhydration of the skin and exposure of the skin to substances contained in bodily waste, or it must contain direct or indirect Agents that provide skin care benefits. For example, indirect efficacy includes improved removal of skin irritants such as feces or urine. The composition can be in a variety of forms including, but not limited to, emulsions, lotions, creams, ointments, salves, powders, suspensions, capsules, gels, and the like.
这里所用的术语“有效量的护肤组合物”指一定量的具体组合物,当施用到或迁移到吸湿用品的一个或多个接触身体面时,随着时间推移,其将有效地提供通过该吸湿用品输送的保护性屏障和/或提供护肤功效。当然,施用到用品上的组合物的有效量在很大程度上将取决于所用的具体组合物。但是,在吸湿用品的至少一部分接触穿用者的表面上的组合物的量的范围优选是约0.05毫克/英寸2(0.0078毫克/厘米2)至约80毫克/英寸2(12.4毫克/厘米2)、更优选是约1毫克/英寸2(0.16毫克/厘米2)至约40毫克/英寸2(6.20毫克/厘米2)、进一步优选是约4毫克/英寸2(0.62毫克/厘米2)至约26毫克/英寸2(4.03毫克/厘米2)。这些范围仅用作举例,本领域普通技术人员将认识到,组合物的性质将决定为达到所需的护肤功效所必须施用的组合物的量,根据本发明的公开内容,这些用量由常规的实验来确定。As used herein, the term "an effective amount of a skin care composition" refers to an amount of a particular composition which, when applied to or migrated to one or more body-contacting surfaces of an absorbent article, will be effective to provide skin care through the skin over time. Absorbent articles deliver a protective barrier and/or provide skin care benefits. The effective amount of the composition applied to the article will, of course, depend largely on the particular composition used. However, the amount of the composition on at least a portion of the absorbent article which contacts the wearer's surface is preferably in the range of about 0.05 mg/in 2 (0.0078 mg/cm 2 ) to about 80 mg/in 2 (12.4 mg/cm 2 ), more preferably about 1 mg/in 2 (0.16 mg/cm 2 ) to about 40 mg/in 2 (6.20 mg/cm 2 ), more preferably about 4 mg/in 2 (0.62 mg/cm 2 ) to About 26 mg/in 2 (4.03 mg/cm 2 ). These ranges are provided as examples only, and those of ordinary skill in the art will recognize that the nature of the composition will determine the amount of composition that must be applied to achieve the desired skin care benefit, and such amounts can be determined from conventional Experiment to determine.
尽管施用到吸湿用品上的护肤组合物的用量是本发明方法的一个重要方面,但是在一种或多种被处理的用品的使用期间输送到穿用者的皮肤上的组合物的用量是更为重要的。尽管为提供所需的护肤功效而必须输送到皮肤上的用量在一定程度上将取决于所采用的组合物的性质,申请人已发现,可以仅输送相当低的用量,同时仍能提供所需的皮肤效果。这对于优选的组合物尤其是这样。Although the amount of skin care composition applied to an absorbent article is an important aspect of the methods of the present invention, the amount of composition delivered to the wearer's skin during use of one or more treated articles is more important. as important. Although the amount that must be delivered to the skin to provide the desired skin care benefit will depend to some extent on the nature of the composition employed, applicants have found that relatively low amounts can be delivered while still providing the desired skin care benefits. skin effect. This is especially true for the preferred compositions.
本发明方法的另一个好处是控制护肤组合物的施用以提供所需的低但有效用量的组合物。这与护肤剂的典型的不规则的手工施用不同,在那种情况下,护理者/使用者通常将施用比所需要的大很多的量。由于从皮肤输送到用品上的结果,手工加入的过多的材料对吸湿用品的流体处理性能也可能产生不利的影响。确实,对于某些材料如矿脂来说,手工施用的量可能实际导致闭塞效果,从而损害皮肤。本发明方法的一个好处是对表面水分提供一个屏障,同时避免皮肤的闭塞(即,保持皮肤透气性)。因此,本发明方法在整个佩戴期间对组合物的输送进行控制,这将使最适宜量的组合物输送到皮肤上以保持和/或改善皮肤健康。Another benefit of the method of the present invention is to control the application of the skin care composition to provide the desired low but effective amount of the composition. This is in contrast to the typical sporadic manual application of skin care agents where the caregiver/user will often apply a much larger amount than required. Excessive material added by hand may also adversely affect the fluid handling properties of the absorbent article as a result of transport from the skin to the article. Indeed, with some materials, such as petrolatum, the amount applied by hand may actually result in an occlusive effect, thereby damaging the skin. One benefit of the method of the present invention is to provide a barrier to surface moisture while avoiding occlusion of the skin (ie, maintaining skin breathability). Thus, the method of the present invention controls the delivery of the composition throughout the wearing period, which will deliver an optimum amount of the composition to the skin to maintain and/or improve skin health.
对于使用一个经处理的吸湿用品约3小时(典型的白天佩戴时间)期间输送到穿用者上的护肤组合物的用量来说,优选的用量是在3小时佩戴期间至少约0.01毫克/英寸2(0.0016毫克/厘米2)、更优选至少约0.05毫克/英寸2(0.0078毫克/厘米2)、进一步优选至少约0.1毫克/英寸2(0.016毫克/厘米2)的组合物输送到皮肤上。通常,一个经处理的用品在3小时佩戴期间所输送的组合物的用量是约0.01毫克/英寸2(0.0016毫克/厘米2)至约5毫克/英寸2(0.78毫克/厘米2)、更优选是约0.05毫克/英寸2(0.0078毫克/厘米2)至约3毫克/英寸2(0.47毫克/厘米2)、进一步优选是约0.1毫克/英寸2(0.016毫克/厘米2)至约2毫克/英寸2(0.31毫充/厘米2)。For the amount of skin care composition delivered to the wearer during about 3 hours ( typical daytime wear time) of a treated absorbent article, the preferred amount is at least about 0.01 mg/in during 3 hours of wear (0.0016 mg/cm 2 ), more preferably at least about 0.05 mg/in 2 (0.0078 mg/cm 2 ), still more preferably at least about 0.1 mg/in 2 (0.016 mg/cm 2 ) of the composition is delivered to the skin. Typically, a treated article delivers the composition in an amount of about 0.01 mg/in 2 (0.0016 mg/cm 2 ) to about 5 mg/in 2 (0.78 mg/cm 2 ), more preferably is about 0.05 mg/in 2 (0.0078 mg/cm 2 ) to about 3 mg/in 2 (0.47 mg/cm 2 ), more preferably about 0.1 mg/in 2 (0.016 mg/cm 2 ) to about 2 mg/in in 2 (0.31 millicharge/cm 2 ).
对于如在24小时期间连续使用经处理的用品来说(换句话说,根据常规的使用方式进行更换的情况,通常包括白天每3至4小时换一次以及在夜间睡觉前换一个新的用品),优选的是在24小时期间至少约0.03毫克/英寸2(0.0047毫克/厘米2)、更优选至少约0.1毫克/英寸2(0.016毫克/厘米2)、进一步优选至少约0.3毫克/英寸2(0.047毫克/厘米2)的组合物输送到穿用者的皮肤上。通常,在每次更换时均施用经处理的用品的24小时以后,输送的组合物的量是约0.03毫克/英寸2(0.0047毫克/厘米2)至约18毫克/英寸2(2.79毫克/厘米2)、更优选是约0.1毫克/英寸2(0.016毫克/厘米2)至约10毫克/英寸2(1.55毫克/厘米2)、进一步优选是约0.3毫克/英寸2(0.047毫克/厘米2)至约6毫克/英寸2(0.93毫克/厘米2)。For such cases where treated supplies are used continuously over a 24-hour period (in other words, where changes are made according to a regular pattern of use, which typically includes changing every 3 to 4 hours during the day and a new supply at night before going to bed) , preferably at least about 0.03 mg/in 2 (0.0047 mg/cm 2 ), more preferably at least about 0.1 mg/in 2 (0.016 mg/cm 2 ), more preferably at least about 0.3 mg/in 2 ( 0.047 mg/cm 2 ) of the composition is delivered to the skin of the wearer. Typically, the amount of composition delivered is from about 0.03 mg/in 2 (0.0047 mg/cm 2 ) to about 18 mg/in 2 (2.79 mg/cm 2 ), more preferably about 0.1 mg/in 2 (0.016 mg/cm 2 ) to about 10 mg/in 2 (1.55 mg/cm 2 ), still more preferably about 0.3 mg/in 2 (0.047 mg/cm 2 ) to about 6 mg/in 2 (0.93 mg/cm 2 ).
应当认识到,在根据本发明的方法输送到皮肤上的护肤组合物中所用的多种材料来说,那些被认为是安全有效的护肤剂的材料是本发明所用的合理的材料。这类材料包括美国联邦食品和医药管理局(FDA)关于非处方药人类使用的皮肤保护药品的暂行最终规定中所定义的第I类活性物质,其目前包括:alantoin,氢氧化铝凝胶、锌膏、可可油、聚二甲基硅氧烷、鳕鱼肝油(混合)、甘油、高岭土、凡士林、羊毛脂、矿物油、鲨鱼肝油、白凡士林、滑石、局部淀粉、醋酸锌、碳酸锌、氧化锌等。其它可能使用的材料是美国联邦食品和医药管理局(FDA)关于非处方药的人用皮肤保护药品的暂行最终规定中所限定的第III类活性物质,其目前包括:活酵母细胞衍生物、aldioxa、醋酸铝、微孔纤维素、维生素D3、胶体燕麦粉、半胱氨酸盐酸盐、泛醇、秘鲁香脂油、蛋白质水解物、外消旋的蛋氨酸、碳酸氢钠、维生素A等。It will be appreciated that of the many materials used in skin care compositions that are delivered to the skin according to the methods of the present invention, those materials that are considered safe and effective skin care agents are reasonable materials for use in the present invention. This class of materials includes Class I active substances as defined in the U.S. Federal Food and Drug Administration's (FDA) interim final rule for over-the-counter skin protection drug products for human use, which currently includes: alantoin, aluminum hydroxide gel, zinc paste , cocoa butter, dimethicone, cod liver oil (blended), glycerin, kaolin, petrolatum, lanolin, mineral oil, shark liver oil, white petrolatum, talc, topical starch, zinc acetate, zinc carbonate, zinc oxide, etc. . Other materials that may be used are Class III active substances as defined in the U.S. Federal Food and Drug Administration (FDA) Interim Final Rule for Over-the-Counter Human Skin Protection Drug Products, which currently include: live yeast cell derivatives, aldioxa, Aluminum acetate, microporous cellulose, vitamin D 3 , colloidal oat flour, cysteine hydrochloride, panthenol, Peruvian balsam oil, protein hydrolyzate, racemic methionine, sodium bicarbonate, vitamin A, etc.
许多FDA规定的护肤成分目前已用在市售的护肤产品中,如A+D软膏、Vaseline石油冻、Desitin尿布疹软膏和Daily Care软膏、GoldBond药用婴儿粉、Aquaphor治疗软膏、Baby Magic婴儿润肤液、Johnson’s Ultra Sensitive婴儿膏、Johnson’s婴儿润肤液、唇膏等。这些市售产品可以施用到吸湿用品上以产生本发明方法中所用的经处理的用品,对这些产品进行改性或不进行改性以方便其通过该新方法进行输送。Many FDA-regulated skin care ingredients are currently used in commercially available skin care products such as A+D® Ointment, Vaseline® Petroleum Jelly, Desitin® Diaper Rash Ointment and Daily Care Ointment, GoldBond® Medicated Baby Powder, Aquaphor® Treatment Ointment , Baby Magic® Baby Lotion, Johnson's Ultra Sensitive® Baby Balm, Johnson's Baby Lotion, Lip Balm, etc. These commercially available products can be applied to absorbent articles to produce treated articles for use in the methods of the present invention, with or without modifications to facilitate their delivery by the novel method.
如下文所述,本发明方法中所用的护肤组合物虽不必但优选具有熔点分布,使得在室温下该组合物可相对固定和局限于用品的接触穿用者的表面上,在体温下容易输送至穿用者,并且,在极端贮存条件下仍不完全是液体。优选该组合物通过正常接触、穿用者运动和/或体热易转移到皮肤上。因为该组合物优选基本固定于用品的接触穿用者的表面上,所以,只需要相对低用量的护肤组合物来赋予所希望的护肤益处。另外,在包装本发明方法中所用的经处理的用品时,无需特别的阻隔或包装材料。As described below, the skin care compositions used in the methods of the present invention preferably, though not necessarily, have a melting point distribution such that the compositions are relatively immobilized and localized on the wearer-contacting surface of the article at room temperature and readily delivered at body temperature. to the wearer and, under extreme storage conditions, is still not completely liquid. Preferably the composition is readily transferable to the skin by normal contact, wearer movement and/or body heat. Because the composition is preferably substantially immobilized on the wearer-contacting surface of the article, relatively low levels of the skin care composition are required to impart the desired skin care benefit. Additionally, no special barrier or packaging material is required in packaging the treated articles used in the methods of the present invention.
在优选的实施方案中,本发明所用的护肤组合物在20℃即环境温度下为固体、更通常为半固体。“半固体”指该组合物具有假塑性或塑性液体的流变性。若不施加剪切,该组合物的外观为半固体,但随剪切速度提高,组合物变为流动。这是因为尽管该组合物主要包括固体组分,但它也包括一些少量液体组分。优选,本发明的组合物的零剪切粘度约为1.0×106厘泊至约1.0×108厘泊,更优选为约5.0×106厘泊至约5.0×107厘泊。本文所用术语“零剪切粘度”指在很低的剪切速度下(例如1.0秒-1)用盘和锥式粘度计测定的粘度;一种合适的仪器是从New Castle,DE的TA仪表公司以CSL100型号购得。本领域的普通技术人员将会认识到可使用除高熔点组分(如下所述)之外的其它组分以提供可比较的含有这类组分的组合物的测定粘度,零剪切粘度是通过这类组合物的粘度对剪切速率的曲线外推到在约20℃下的零剪切速率而测定的。In a preferred embodiment, the skin care compositions used in the present invention are solid, more usually semi-solid at 20°C, ie ambient temperature. "Semi-solid" means that the composition has the rheology of a pseudoplastic or plastic liquid. If no shear is applied, the composition has a semi-solid appearance, but as the shear rate is increased, the composition becomes fluid. This is because although the composition mainly includes solid components, it also includes some minor liquid components. Preferably, the compositions of the present invention have a zero shear viscosity of from about 1.0 x 106 centipoise to about 1.0 x 108 centipoise, more preferably from about 5.0 x 106 centipoise to about 5.0 x 107 centipoise. The term "zero shear viscosity" as used herein refers to the viscosity measured with a disk and cone viscometer at very low shear rates (e.g., 1.0 sec -1 ); a suitable instrument is TA Instruments from New Castle, DE The company purchased it as the CSL100 model. One of ordinary skill in the art will recognize that other components than high melting point components (described below) may be used to provide comparable measured viscosities for compositions containing such components, the zero shear viscosity being Determined by extrapolation of viscosity versus shear rate curves for such compositions to zero shear rate at about 20°C.
优选的组合物至少在室温下为半固体以使组合物迁移最小。另外,组合物的最终熔点(100%液体)优选高于可能“苛刻”的贮存条件(大于45℃)(例如,Arizona的仓库、Florida的车体等)。具有这些熔点特性的代表性的组合物在美国专利5,643,588(Roe等)、5,607,760(Roe等)、5,609,587和5,635,191中作了详细描述,将其公开内容引入本发明作为参考。特别是,优选的组合物具有下表所示的熔点分布:Preferred compositions are semisolid at least at room temperature to minimize migration of the composition. In addition, the final melting point (100% liquid) of the composition is preferably above the storage conditions (greater than 45°C) that may be "harsh" (eg, warehouse in Arizona, car body in Florida, etc.). Representative compositions having these melting point characteristics are described in detail in US Pat. Nos. 5,643,588 (Roe et al.), 5,607,760 (Roe et al.), 5,609,587 and 5,635,191, the disclosures of which are incorporated herein by reference. In particular, preferred compositions have the melting point distribution shown in the following table:
由于在环境温度下为固体或半固体,所以优选的组合物流到并迁移到其将要施用的吸湿用品的不希望的区域内的趋势不会很大。这意味着只需要较少的护肤组合物就可赋予理想的治疗、保护性和/或调理好处。By being solid or semi-solid at ambient temperature, the preferred compositions have less tendency to run off and migrate into undesired areas of the absorbent article to which they are applied. This means that less skin care composition is required to impart the desired therapeutic, protective and/or conditioning benefits.
为了增加优选的组合物的固定性,配制的组合物的粘度应尽可能地高,从而防止流到用品内的不希望的区域。不幸的是,在某些情况下,粘度高可能会抑制组合物输送到穿用者的皮肤上。因此,粘度应当达到一个平衡;粘度足够高以使组合物固定于用品的表面上,又不会太高而阻碍其输送到穿用者的皮肤上。组合物用的合适的粘度一般为约5-500厘泊,优选约5-300厘泊,更优选约5-100厘泊,在60℃采用旋转粘度计测量(一种适合的粘度计可由Melrose Park,IL的Lab Line仪器公司以4537型号购得)。该粘度计使用2号锭子在60rpm下操作。In order to increase the fixity of the preferred compositions, the viscosity of the formulated composition should be as high as possible to prevent flow to undesired areas within the article. Unfortunately, in some instances, high viscosity may inhibit the delivery of the composition to the wearer's skin. Accordingly, the viscosity should be balanced; high enough to anchor the composition on the surface of the article, but not so high that it impedes delivery to the wearer's skin. Suitable viscosities for compositions are generally about 5-500 centipoise, preferably about 5-300 centipoise, more preferably about 5-100 centipoise, as measured at 60°C using a rotational viscometer (a suitable viscometer is available from Melrose Lab Line Instruments, Park, IL, as model 4537). The viscometer was operated at 60 rpm using spindle number 2.
对于设计用来提供皮肤光滑性益处的组合物来说,这些组合物中的一种有用的活性成分是一种或多种皮肤保护剂和/或润滑剂。在此所使用的“润滑剂(emollient)”是防止润湿或刺激、柔软、软化、光滑、涂覆、润滑、保湿、保护和/或清洁皮肤的材料。应当认识到,前面列出的规定的几种活性物质正是此处所定义的润滑剂。在优选的实施方案中,这些润滑剂在室温即20℃下具有塑性或液体稠度。该特定的润滑剂稠度使组合物赋予柔软、润滑和润肤液状感觉。For compositions designed to provide skin smoothness benefits, a useful active ingredient in such compositions is one or more skin protectants and/or emollients. As used herein, an "emollient" is a material that prevents wetting or irritation, softens, softens, smoothes, coats, lubricates, moisturizes, protects and/or cleanses the skin. It should be recognized that the specified actives listed above are lubricants as defined herein. In a preferred embodiment, these lubricants have a plastic or liquid consistency at room temperature, ie 20°C. This particular emollient consistency imparts a soft, lubricious and lotion-like feel to the composition.
用于本发明的代表性的润滑剂包括,但不限于下列润滑剂:石油基类;多元醇多酯;蔗糖脂肪酸酯类;聚乙二醇及其衍生物;润湿剂;脂肪酸酯类;烷基乙氧基化物类;脂肪酸酯乙氧基化物类;脂肪醇类;聚硅氧烷类;丙二醇及其衍生物类;甘油及其衍生物(包括甘油酯、乙酰甘油酯和C12-C28脂肪酸的乙氧基化的甘油酯),三甘醇及其衍生物类;鲸蜡或其它的蜡;脂肪酸;脂肪醇醚(特别是脂肪链长具有12-28个碳原子的物质,如硬脂酸);丙氧基化的脂肪醇;多羟基醇的其它脂肪酯;羊毛脂及其衍生物;高岭土及其衍生物;前面所列的任何规定的护肤剂;或这些润滑剂的混合物。合适的石油基润滑剂包括具有16-32个碳原子链长的那些烃,或这些烃的混合物。带有这些链长的石油基烃包括矿物油(也称之为“液体凡士林”)和凡士林(也称之为“地蜡”,“石油冻”和“矿物冻”)。矿物油通常指的是较低粘度的、且带有16-20个碳原子的烃的混合物。凡士林通常指的是更为粘稠的、且带有16-32个碳原子的烃的混合物。凡士林和矿物油是本发明组合物所用的特别优选的润滑剂。Representative lubricants useful in the present invention include, but are not limited to, the following lubricants: petroleum-based; polyol polyesters; sucrose fatty acid esters; polyethylene glycol and its derivatives; wetting agents; fatty acid esters; Alkyl ethoxylates; fatty acid ester ethoxylates; fatty alcohols; polysiloxanes; propylene glycol and its derivatives; glycerin and its derivatives (including glycerides, acetylglycerides and C12 - Ethoxylated glycerides of C28 fatty acids), triethylene glycol and its derivatives; spermaceti or other waxes; fatty acids; fatty alcohol ethers (especially substances with a fatty chain length of 12-28 carbon atoms , such as stearic acid); propoxylated fatty alcohols; other fatty esters of polyhydric alcohols; lanolin and its derivatives; kaolin and its derivatives; any of the prescribed skin care agents listed above; or these emollients mixture. Suitable petroleum-based lubricants include those hydrocarbons having a chain length of 16 to 32 carbon atoms, or mixtures of such hydrocarbons. Petroleum-based hydrocarbons with these chain lengths include mineral oil (also known as "liquid petrolatum") and petrolatum (also known as "ozokerite", "petroleum jelly" and "mineral jelly"). Mineral oil generally refers to a mixture of lower viscosity hydrocarbons having 16-20 carbon atoms. Petroleum jelly generally refers to a more viscous mixture of hydrocarbons with 16-32 carbon atoms. Petrolatum and mineral oil are particularly preferred lubricants for use in the compositions of the present invention.
合适的脂肪酸酯类润滑剂包括由C12-C28脂肪酸,优选由C16-C22饱和脂肪酸,和短链(C1-C8,优选C1-C3)一元醇衍生得到的那些物质。所述酯的代表性的例子包括棕榈酸甲酯、硬脂酸甲酯、月桂酸异丙酯、肉豆蔻酸异丙酯、棕榈酸异丙酯、棕榈酸乙基己酯及其混合物。合适的脂肪酸酯润滑剂也可由更长链脂肪醇(C12-C28,优选C12-C16)和更短链的脂肪酸例如乳酸的酯衍生得到,如乳酸月桂酯和乳酸鲸蜡酯。Suitable fatty acid ester lubricants include those derived from C 12- C 28 fatty acids, preferably C 16- C 22 saturated fatty acids, and short chain (C 1- C 8 , preferably C 1- C 3 ) monohydric alcohols . Representative examples of such esters include methyl palmitate, methyl stearate, isopropyl laurate, isopropyl myristate, isopropyl palmitate, ethylhexyl palmitate, and mixtures thereof. Suitable fatty acid ester lubricants are also derived from esters of longer chain fatty alcohols ( C12- C28 , preferably C12- C16 ) and shorter chain fatty acids such as lactic acid, such as lauryl lactate and cetyl lactate .
合适的烷基乙氧基化物类润滑剂包括平均乙氧基化度为约2至约30的C12-C22脂肪醇乙氧基化物。优选的脂肪醇乙氧基化物润滑剂选自:平均乙氧基化度为约2至约23的月桂基、鲸蜡基和硬脂基乙氧基化物,及其混合物。所述烷基乙氧基化物的代表性的例子包括:十二烷基聚氧乙烯醚-3(平均乙氧基化度为3的月桂基乙氧基化物),十二烷基聚氧乙烯醚-23(平均乙氧基化度为23的月桂基乙氧基化物),十六烷基聚氧乙烯醚-10(平均乙氧基化度为10的鲸蜡醇乙氧基化物),十八烷基聚氧乙烯醚-10(平均乙氧基化度为10的硬脂醇乙氧基化物)。当使用这些烷基乙氧基化物润滑剂时,其通常与石油基润滑剂如凡士林结合使用,烷基乙氧基化物润滑剂与石油基润滑剂的重量比从约1∶1至约1∶5,优选从约1∶2至约1∶4。Suitable alkyl ethoxylate-based lubricants include C12- C22 fatty alcohol ethoxylates having an average degree of ethoxylation of from about 2 to about 30. Preferred fatty alcohol ethoxylate lubricants are selected from the group consisting of lauryl, cetyl and stearyl ethoxylates having an average degree of ethoxylation of from about 2 to about 23, and mixtures thereof. Representative examples of the alkyl ethoxylates include: laureth-3 (lauryl ethoxylate with an average degree of ethoxylation of 3), laureth Ether-23 (lauryl ethoxylate with an average degree of ethoxylation of 23), ceteth-10 (cetyl alcohol ethoxylate with an average degree of ethoxylation of 10), Stearyl Ethoxylate-10 (stearyl alcohol ethoxylate with an average degree of ethoxylation of 10). When these alkyl ethoxylate lubricants are used, they are typically used in combination with petroleum-based lubricants such as petrolatum at a weight ratio of alkyl ethoxylate lubricant to petroleum-based lubricant of from about 1:1 to about 1:1: 5, preferably from about 1:2 to about 1:4.
合适的脂肪醇类润滑剂包括C12-C22的脂肪醇,优选为C16-C18的脂肪醇。代表性的例子包括鲸蜡醇和硬脂醇,及其混合物。当使用这些脂肪醇润滑剂时,其通常与石油基润滑剂如凡士林结合使用,脂肪醇润滑剂对石油基润滑剂的重量比从约1∶1至约1∶5,优选从约1∶1至约1∶2。Suitable fatty alcohol lubricants include C 12- C 22 fatty alcohols, preferably C 16- C 18 fatty alcohols. Representative examples include cetyl alcohol and stearyl alcohol, and mixtures thereof. When these fatty alcohol lubricants are used, they are typically used in combination with petroleum based lubricants such as petrolatum at a weight ratio of fatty alcohol lubricant to petroleum based lubricant of from about 1:1 to about 1:5, preferably from about 1:1 to about 1:2.
其它种类的适用于本发明的润滑剂包括聚硅氧烷化合物。通常用于本发明的合适的聚硅氧烷材料包括具有下面结构的单体硅氧烷单元的那些材料:Other classes of lubricants suitable for use in the present invention include silicone compounds. Suitable polysiloxane materials generally useful in the present invention include those materials having monomeric siloxane units of the following structure:
式中,对于每个独立的硅氧烷单体单元而言,R1和R2可彼此独立地为氢或任何烷基、芳基、链烯基、烷芳基、芳烷基、环烷基、卤代烃,或其它的基团。这些基团中的任何一种可以是取代的或未取代的。任何特定单体单元中的R1和R2可以不同于下一个连接的单体单元的相应的官能团。此外,聚硅氧烷可以是直链、支链或者具有环状结构。另外,基团R1和R2可彼此独立地为其它的含硅官能团如(但不局限于)硅氧烷、聚硅氧烷、硅烷和聚硅烷。基团R1和R2还可包含任何有机官能团,所述官能团例如包括醇、羧酸、苯基和胺官能团。In the formula, for each independent siloxane monomer unit, R1 and R2 can independently be hydrogen or any alkyl, aryl, alkenyl, alkaryl, aralkyl, cycloalkane groups, halogenated hydrocarbons, or other groups. Any of these groups may be substituted or unsubstituted. R1 and R2 in any particular monomeric unit may be different from the corresponding functional groups of the next linked monomeric unit. In addition, polysiloxane may be linear, branched, or have a cyclic structure. Additionally, the groups R1 and R2 may independently of each other be other silicon-containing functional groups such as, but not limited to, siloxanes, polysiloxanes, silanes, and polysilanes. The groups R1 and R2 may also comprise any organic functional groups including, for example, alcohol, carboxylic acid, phenyl and amine functional groups.
举例性的烷基基团为甲基、乙基、丙基、丁基、戊基、己基、辛基、癸基、十八烷基等。举例性的链烯基为乙烯基,烯丙基等。举例性的芳香基为苯基、联苯基、萘基等。举例性的烷芳基为甲苯基、二甲苯基、乙苯基等。举例性的芳烷基为苄基、α-苯乙基、β-苯乙基、α-苯丁基等。举例性的环烷基基团为环丁基、环戊基、环己基等。举例性的卤代烃基团为氯甲基、溴乙基、四氟乙基、氟乙基、三氟乙基、三氟甲苯基、六氟二甲苯基等。Exemplary alkyl groups are methyl, ethyl, propyl, butyl, pentyl, hexyl, octyl, decyl, octadecyl, and the like. Exemplary alkenyl groups are vinyl, allyl and the like. Exemplary aryl groups are phenyl, biphenyl, naphthyl and the like. Exemplary alkaryl groups are tolyl, xylyl, ethylphenyl, and the like. Exemplary aralkyl groups are benzyl, α-phenethyl, β-phenethyl, α-phenbutyl, and the like. Exemplary cycloalkyl groups are cyclobutyl, cyclopentyl, cyclohexyl, and the like. Exemplary halohydrocarbyl groups are chloromethyl, bromoethyl, tetrafluoroethyl, fluoroethyl, trifluoroethyl, trifluoromethylphenyl, hexafluoroxylyl, and the like.
只要聚硅氧烷可以流动或用于吸湿用品上时可使之流动,那么有用的聚硅氧烷的粘度可以如聚硅氧烷的粘度通常变化那样尽可能大地变化。这包括但不局限于低至5厘沲(于37℃通过玻璃粘度计测量)至约20,000,000厘沲。优选在37℃时聚硅氧烷的粘度从约5至约5,000厘沲,更优选从约5至约2,000厘沲,最佳从约100至约1000厘沲。通过如将聚硅氧烷在表面活性剂中乳化,或借助于溶剂如己烷(只是举例性的)提供聚硅氧烷溶液这样的方法,能将其本身抗流动的高粘度聚硅氧烷有效地沉积在吸湿用品上。在下面将更为详细地讨论将聚硅氧烷润滑剂加至吸湿用品上的特定方法。The viscosities of useful silicones can vary as much as silicones typically vary in viscosity so long as the silicones flow or are made to flow when used in absorbent articles. This includes, but is not limited to, as low as 5 centistokes (measured by a glass viscometer at 37°C) to about 20,000,000 centistokes. Preferably the polysiloxane has a viscosity at 37°C of from about 5 to about 5,000 centistokes, more preferably from about 5 to about 2,000 centistokes, most preferably from about 100 to about 1000 centistokes. High-viscosity polysiloxanes that are inherently resistant to flow by methods such as emulsifying the polysiloxane in a surfactant, or providing a solution of the polysiloxane with the aid of a solvent such as hexane (for example only) Effective deposition on absorbent articles. Particular methods of adding silicone lubricants to absorbent articles are discussed in more detail below.
用于本发明的优选的聚硅氧烷化合物披露于1991年10月22日授予Ampulski等人的美国专利5,059,282中,该文献在此引入作为参考。可用作本发明组合物中的润滑剂的特别优选的聚硅氧烷化合物包括:带苯基官能团的聚甲基硅氧烷化合物(例如,Dow Corning 556 Cosmetic-Grade Fluid:聚苯基甲基硅氧烷)和鲸蜡基或十八烷基官能化的聚二甲基硅氧烷,如分别为Dow2502和Dow 2503的聚硅氧烷流体。除了带有苯基官能团或烷基基团这样的取代基以外,有效的取代基还有氨基、羧基、羟基、醚、聚醚、醛、酮、酰胺、酯以及硫醇基团。在这些有效取代基中,包含苯基、氨基、烷基、羧基和羟基的这类基团比其它基团更为优选;最优选的是苯基官能团。Preferred silicone compounds for use in the present invention are disclosed in US Patent 5,059,282, Ampulski et al., issued October 22, 1991, which is incorporated herein by reference. Particularly preferred silicone compounds useful as lubricants in the compositions of the present invention include: phenyl-functional polymethylsiloxane compounds (e.g., Dow Corning 556 Cosmetic-Grade Fluid: polyphenylmethyl siloxane) and cetyl or octadecyl functionalized polydimethylsiloxanes such as Dow 2502 and Dow 2503 polysiloxane fluids respectively. In addition to substituents with phenyl functions or alkyl groups, effective substituents are also amino, carboxyl, hydroxyl, ether, polyether, aldehyde, ketone, amide, ester and thiol groups. Of these available substituents, those containing phenyl, amino, alkyl, carboxyl, and hydroxy are preferred over others; most preferred is the phenyl function.
合适的润湿剂包括:甘油、丙二醇、山梨醇、三羟基硬脂精等。Suitable wetting agents include: glycerin, propylene glycol, sorbitol, trihydroxystearin, and the like.
组合物中所含的润滑剂的量将取决于各种因素,包括所涉及的特定的润滑剂、所希望的润肤益处、组合物中的其它组分等因素。所述组合物可包含占总重量约0-100%的润滑剂。优选的是,所述组合物包含约10-95%重量,更优选约20-80%,最佳约40-75%重量的润滑剂。The amount of emollient included in the composition will depend on various factors including the particular emollient involved, the emollient benefit desired, other components of the composition, and the like. The composition may contain a lubricant in an amount of about 0-100% by total weight. Preferably, the composition comprises from about 10-95% by weight lubricant, more preferably from about 20-80%, most preferably from about 40-75%.
用于本发明方法中的治疗/保护皮肤/调理皮肤的组合物中的一任选的且优选的组分是能将组合物(包括优选的润滑剂和/或其它皮肤调理/治疗/保护试剂)固定在经处理的用品内或其上的所需部位上的试剂。由于组合物中某些优选的润滑剂在20℃具有塑性或流体稠度,所以润滑剂往往具有流动或发生迁移的趋势,即使在受到适度的剪切时也是如此。当将润滑剂施加至吸湿用品的接触穿用者的表面或其它部位上时,尤其是处于熔化或熔融状态时,润滑剂将不能保持主要在经处理的区域内或其上。相反,该润滑剂往往将迁移和流至用品的不需要的区域内。An optional and preferred component of the skin treatment/protection/skin conditioning compositions used in the methods of the present invention is the ability to incorporate the composition (including preferably emollients and/or other skin conditioning/treatment/protection agents) ) An agent immobilized at a desired location in or on a treated article. Because certain preferred lubricants in the composition have a plastic or fluid consistency at 20°C, the lubricants tend to have a tendency to flow or migrate even when subjected to moderate shear. When the lubricant is applied to the wearer contacting surface or other portion of the absorbent article, especially in a molten or melted state, the lubricant will not remain primarily in or on the treated area. Instead, the lubricant will tend to migrate and flow into unwanted areas of the article.
具体地讲,如果润滑剂迁移入用品的内部,其可能会对用品吸湿芯的吸收性产生不希望的影响,这是用于本发明的方法中的组合物中所用的许多润滑剂和其它皮肤调理剂的疏水特性所导致。这也意味着需要向用品上施用多得多的润滑剂以获得所需的皮肤光滑性功效。增加润滑剂的用量不仅增加成本,而且还使对用品的吸湿芯的不利影响和在经处理的用品的加工/改装期间组合物的不利输送加剧。In particular, if the lubricant migrates into the interior of the article, it may have an undesired effect on the absorbency of the article's absorbent core, as is the case with many lubricants and other skin care agents used in compositions used in the methods of the present invention. Due to the hydrophobic nature of the conditioner. This also means that much more lubricant needs to be applied to the article to obtain the desired skin smoothness benefits. Increased lubricant levels not only increase cost, but also exacerbate adverse effects on the absorbent core of the article and poor delivery of the composition during processing/reconstruction of the treated article.
通过使润滑剂主要固定在组合物将要施加的用品的表面上或区域内,固定剂抵消了润滑剂迁移或流动的这种趋势。据信,这部分是由于固定剂将组合物的熔点和/或粘度提高到润滑剂的熔点和/或粘度之上的事实。由于固定剂优选与润滑剂混溶(或借助适当的乳化剂溶解在润滑剂中),因此,它还将润滑剂截留在用品的接触穿用者的表面上或润滑剂将要施加的区域内。The immobilizing agent counteracts this tendency of the lubricant to migrate or flow by primarily immobilizing the lubricant on the surface or within the area of the article to which the composition will be applied. This is believed to be due in part to the fact that the fixative raises the melting point and/or viscosity of the composition above that of the lubricant. Since the fixative is preferably miscible with (or soluble in) the lubricant with the aid of a suitable emulsifier, it also traps the lubricant on the wearer contacting surface of the article or in the area where the lubricant is to be applied.
将固定剂“锁定”在其将要施加的用品的接触穿用者的表面或区域上也是有利的。这可通过使用在施加到用品上时将快速“固定”(或固化)的固定剂来实现。此外,通过鼓风机、风扇、冷却辊等对经处理的用品进行外部冷却可加速固定剂的结晶。It is also advantageous to "lock" the fixative onto the wearer-contacting surface or area of the article to which it is applied. This can be achieved by using a fixative that will "set" (or cure) quickly when applied to the article. In addition, external cooling of the treated article by means of blowers, fans, chill rolls, etc. can accelerate the crystallization of the fixative.
除了能与润滑剂混溶(或溶解于其中)以外,该固定剂优选具有这样的熔点分布,即其将提供在环境温度下是固体或半固体的组合物。在这方面,优选的固定剂的熔点至少约35℃。这样的话,该固定剂本身将不会有迁移或流动的趋势。优选的固定剂的熔点至少约40℃。通常,固定剂的熔点范围为从约50℃至约150℃。In addition to being miscible with (or soluble in) the lubricant, the fixative preferably has a melting point distribution that will provide a composition that is solid or semi-solid at ambient temperature. In this regard, preferred fixatives have a melting point of at least about 35°C. As such, the fixative itself will not have a tendency to migrate or flow. Preferred fixatives have a melting point of at least about 40°C. Typically, the fixative has a melting point in the range of from about 50°C to about 150°C.
当用于本发明中时,适合的固定剂可以选自许多试剂中的任何一种,只要护肤组合物的优选性质提供本发明所述的皮肤好处。优选的固定剂将包括:选自多羟基脂肪酸酯、多羟基脂肪酸酰胺、C14-C22脂肪醇、C12-C22脂肪酸和平均乙氧基化度为约2-30的C12-C22脂肪醇乙氧基化物及其混合物的固定剂。优选的固定剂包括:C16-C18脂肪醇,最优选的结晶高熔点物质选自:鲸蜡醇、硬脂醇、二十二醇及其混合物。这些物质的线性结构可以加速在经处理的用品上的固化。鲸蜡醇和硬脂醇的混合物是特别优选的。其它优选的固定剂包括:C16-C18脂肪酸,最优选选自:棕榈酸、硬脂酸及其混合物。棕榈酸和硬脂酸的混合物是特别优选的。还有其它优选的固定剂包括:平均乙氧基化度从约5至约20的C16-C18脂肪醇乙氧基化物。优选脂肪醇、脂肪酸和脂肪醇乙氧基化物是线性的。重要的是,这些优选的固定剂如C16-C18脂肪醇增加了组合物的结晶速率,使组合物在基质的表面上快速结晶。When used in the present invention, suitable immobilizing agents may be selected from any of a number of agents so long as the preferred properties of the skin care composition provide the skin benefits described herein. Preferred immobilizing agents will include: selected from polyhydroxy fatty acid esters, polyhydroxy fatty acid amides, C 14- C 22 fatty alcohols, C 12- C 22 fatty acids and C 12-C 22 fatty acids with an average degree of ethoxylation of about 2-30. Fixative for C22 fatty alcohol ethoxylates and mixtures thereof. Preferred fixatives include: C16- C18 fatty alcohols, most preferred crystalline high melting point substances are selected from: cetyl alcohol, stearyl alcohol, behenyl alcohol and mixtures thereof. The linear structure of these materials accelerates cure on treated articles. Mixtures of cetyl alcohol and stearyl alcohol are particularly preferred. Other preferred fixatives include: C16- C18 fatty acids, most preferably selected from: palmitic acid, stearic acid and mixtures thereof. Mixtures of palmitic and stearic acids are particularly preferred. Still other preferred fixatives include: C16- C18 fatty alcohol ethoxylates having an average degree of ethoxylation of from about 5 to about 20. Preferably the fatty alcohols, fatty acids and fatty alcohol ethoxylates are linear. Importantly, these preferred fixatives such as C16- C18 fatty alcohols increase the rate of crystallization of the composition, allowing the composition to crystallize rapidly on the surface of the substrate.
或者单独使用,或者可与上述固定剂结合使用的、可用作固定剂的其它类型的配料包括蜡,如巴西棕榈蜡,地蜡,蜂蜡,小烛树蜡,石蜡,地蜡,西班牙草蜡,小冠椰子蜡,rezowax,异石蜡和其它已知的混合和矿物蜡。这些物质的高熔点可有助于将组合物固定在吸湿用品上的所希望的表面或部位上。另外,微晶蜡也是有效的固定剂。微晶蜡有助于将低分子量的烃“锁定”在护肤组合物中。优选的蜡是石蜡。特别优选的另一种固定剂的实例是石蜡如ParrafinS.P.434(得自Strahl and Pitsch Inc.P.O.Box 1098 West Babylon,NY11704)。Other types of ingredients that can be used as fixatives, either alone or in combination with the above-mentioned fixatives, include waxes such as carnauba wax, ozokerite, beeswax, candelilla wax, paraffin wax, ozokerite, spanish wax , small crown coconut wax, rezowax, isoparaffin and other known mixed and mineral waxes. The high melting points of these materials can aid in anchoring the composition to the desired surface or location on the absorbent article. In addition, microcrystalline wax is also an effective fixative. Microcrystalline waxes help to "lock" low molecular weight hydrocarbons into skin care compositions. A preferred wax is paraffin. Another example of a particularly preferred fixative is paraffin such as Parrafin S.P. 434 (available from Strahl and Pitsch Inc. P.O. Box 1098 West Babylon, NY 11704).
用于本发明的、合适的多羟基脂肪酸酯将具有如下结构式:Suitable polyhydroxy fatty acid esters for use in the present invention will have the formula:
式中,R是C5-C31烃基,优选是直链C7-C19烷基或烯基,更优选的是直链C9-C14烷基或烯基,最优选的是直链C11-C17烷基或烯基,或其混合物;Y是多羟基烃基部分,其中烃基链至少带2个直接连接至该链上的游离羟基;n至少为1。合适的Y基团可由多元醇如甘油、季戊四醇;糖如棉子糖、麦芽糖葡萄糖、半乳糖、蔗糖、葡萄糖、木糖、果糖、麦芽糖、乳糖、甘露糖和赤藓糖;糖醇如赤藓糖醇、木糖醇、麦芽糖醇、甘露糖醇和山梨醇;以及糖醇酐如脱水山梨糖醇衍生得到。In the formula, R is a C 5- C 31 hydrocarbon group, preferably a straight-chain C 7- C 19 alkyl or alkenyl, more preferably a straight-chain C 9- C 14 alkyl or alkenyl, most preferably a straight-chain C11- C17 alkyl or alkenyl, or mixtures thereof; Y is a polyhydroxyhydrocarbyl moiety in which the hydrocarbyl chain has at least 2 free hydroxyl groups directly attached to the chain; n is at least 1. Suitable Y groups can be composed of polyols such as glycerol, pentaerythritol; sugars such as raffinose, maltose glucose, galactose, sucrose, glucose, xylose, fructose, maltose, lactose, mannose and erythrose; sugar alcohols such as erythrose Derived from sugar alcohols, xylitol, maltitol, mannitol, and sorbitol; and anhydrides of sugar alcohols such as sorbitan.
用于本发明的一类合适的多羟基脂肪酸酯包括某些脱水山梨醇酯,优选C16-C22饱和脂肪酸的脱水山梨醇酯。由于这些脱水山梨醇酯的典型制备方法,因此这些脱水山梨醇酯常常包含单-、二-、三-等酯的混合物。合适的脱水山梨醇酯的代表性例子包括棕榈酸脱水山梨醇酯(例如,SPAN 40)、硬脂酸脱水山梨醇酯(例如,SPAN 60)和二十二烷酸脱水山梨醇酯,其包含这些脱水山梨醇酯的一个或多个的单酯、二酯和三酯,例如棕榈酸脱水山梨醇单酯、二酯和三酯,硬脂酸脱水山梨醇单酯、二酯和三酯,二十二烷酸脱水山梨醇单酯、二酯和三酯,以及混合的牛脂脂肪酸脱水山梨醇单酯、二酯和三酯。另外也可使用不同脱水山梨醇酯的混合物,如棕榈酸脱水山梨醇酯和硬脂酸脱水山梨醇酯的混合物。特别优选的脱水山梨醇酯是硬脂酸脱水山梨醇酯,通常是单酯、二酯和三酯(加上某些四酯)的混合物如SPAN 60,和以商品名GLYCOMUL-S(Lonza,Inc.)出售的硬脂酸脱水山梨醇酯。尽管这些脱水山梨醇酯中通常包含单酯、二酯和三酯,加上某些四酯的混合物,但在这些混合物中,占主要成份的是单酯和二酯。One class of suitable polyhydroxy fatty acid esters for use in the present invention includes certain sorbitan esters, preferably sorbitan esters of C16- C22 saturated fatty acids. Due to the typical method of preparation of these sorbitan esters, these sorbitan esters often comprise mixtures of mono-, di-, tri-, etc. esters. Representative examples of suitable sorbitan esters include sorbitan palmitate (e.g., SPAN 40), sorbitan stearate (e.g., SPAN 60), and sorbitan behenate, which comprise Monoesters, diesters and triesters of one or more of these sorbitan esters, for example sorbitan palmitate monoesters, diesters and triesters, sorbitan stearate monoesters, diesters and triesters, Sorbitan mono-, di-, and triester behenic acids, and mixed sorbitan mono-, di-, and triesters of tallow fatty acids. Alternatively, mixtures of different sorbitan esters may be used, such as a mixture of sorbitan palmitate and sorbitan stearate. A particularly preferred sorbitan ester is sorbitan stearate, usually a mixture of mono-, di-, and triesters (plus some tetra-esters) such as SPAN 60, and under the trade name GLYCOMUL-S (Lonza, Inc.) sorbitan stearate. Although these sorbitan esters generally contain mixtures of monoesters, diesters and triesters, plus some tetraesters, within these mixtures the monoesters and diesters predominate.
另一类用于本发明的、合适的多羟基脂肪酸酯包括:某些甘油单酯,优选的是C16-C22饱和脂肪酸的甘油单酯,如甘油一硬脂酸酯,甘油一棕榈酸酯和甘油一(二十二烷酸)酯。另外,与脱水山梨醇酯一样,甘油一酯的混合物通常将包含某些二酯和三酯。然而,所述的混合物应主要包含将用于本发明的甘油一酯。Another class of suitable polyhydroxy fatty acid esters for use in the present invention includes certain monoglycerides, preferably monoglycerides of C16- C22 saturated fatty acids, such as glyceryl monostearate, glyceryl monopalm Glyceryl mono(behenic acid) ester. Also, as with sorbitan esters, mixtures of monoglycerides will generally contain some di- and triesters. However, said mixture should mainly comprise monoglycerides to be used in the present invention.
另一类用于本发明的、合适的多羟基脂肪酸酯包括某些蔗糖脂肪酸酯,优选蔗糖的C12-C22饱和脂肪酸酯。蔗糖的一酯和二酯是特别优选的,并包括硬脂酸的蔗糖一酯和二酯和月桂酸蔗糖一酯和二酯。Another class of suitable polyhydroxy fatty acid esters for use in the present invention includes certain sucrose fatty acid esters, preferably C12- C22 saturated fatty acid esters of sucrose. Sucrose mono- and diesters are particularly preferred and include sucrose mono- and diesters of stearic acid and sucrose mono- and diesters of laurate.
用于本发明的、合适的多羟基脂肪酸酰胺具有如下结构式:Suitable polyhydroxy fatty acid amides for use in the present invention have the formula:
式中R1为H、C1-C4烃基、2-羟乙基、2-羟丙基、甲氧基乙基、甲氧基丙基或其混合物,优选C1-C4烷基、甲氧基乙基或甲氧基丙基,更优选的是C1或C2烷基或甲氧基丙基,最优选的是C1烷基(即甲基)或甲氧基丙基;R2为C5-C31烃基,优选直链C7-C19烷基或烯基,更优选直链C9-C17烷基或烯基,最优选的是直链C11-C17烷基或烯基,或其混合物;Z是多羟基烃基部分,其中的线性烃基链至少带3个直接连接至该链上的羟基。参见1992年12月29日授予Honsa的美国专利5,174,927(在此引入作为参考),该专利披露了这些多羟基脂肪酸酰胺及其制备方法。In the formula, R is H, C 1- C 4 hydrocarbon group, 2-hydroxyethyl, 2-hydroxypropyl, methoxyethyl, methoxypropyl or a mixture thereof, preferably C 1- C 4 alkyl, Methoxyethyl or methoxypropyl, more preferably C or C alkyl or methoxypropyl, most preferably C alkyl (i.e. methyl) or methoxypropyl; R 2 is a C 5- C 31 hydrocarbon group, preferably a straight-chain C 7- C 19 alkyl or alkenyl group, more preferably a straight-chain C 9- C 17 alkyl or alkenyl group, most preferably a straight-chain C 11- C 17 Alkyl or alkenyl, or mixtures thereof; Z is a polyhydroxyhydrocarbyl moiety in which the linear hydrocarbyl chain has at least 3 hydroxyl groups directly attached to the chain. See US Patent 5,174,927, issued to Honsa on December 29, 1992 (hereby incorporated by reference), which discloses these polyhydroxy fatty acid amides and methods for their preparation.
Z部分优选由还原胺化反应中的还原糖衍生得到;最优选的是缩水糖基(glyc1tyl)。合适的还原糖包括葡萄糖、果糖、麦芽糖、乳糖、半乳糖、甘露糖和木糖。可以使用富含葡萄糖的玉米糖浆,富含果糖的玉米糖浆,和富含麦芽糖的玉米糖浆,以及列于上面的各种糖。这些玉米糖浆可得到用于Z部分的糖组分的混合物。The Z moiety is preferably derived from a reducing sugar in a reductive amination reaction; most preferred is glycidyl. Suitable reducing sugars include glucose, fructose, maltose, lactose, galactose, mannose and xylose. Dextrose-enriched corn syrup, fructose-enriched corn syrup, and maltose-enriched corn syrup can be used, as well as the various sugars listed above. These corn syrups can yield a mixture of sugar components for Part Z.
Z部分优选选自-CH2-(CHOH)n-CH2OH、-CH(CH2OH)-[(CHOH)n-1]-CH2OH、-CH2OH-CH2-(CHOH)2(CHOR3)(CHOH)-CH2OH,式中n是3-5的整数,R3为H或环状或脂族单糖。最优选的是其中n为4的缩水糖基,特别是-CH2-(CHOH)4-CH2OH。The moiety Z is preferably selected from -CH2- (CHOH) n - CH2OH , -CH( CH2OH )-[(CHOH) n-1 ] -CH2OH , -CH2OH - CH2- (CHOH) 2 (CHOR 3 )(CHOH)-CH 2 OH, wherein n is an integer of 3-5, and R 3 is H or a cyclic or aliphatic monosaccharide. Most preferred are glycidyl groups wherein n is 4, especially -CH2- (CHOH) 4- CH2OH .
在上述结构式中,R1可为例如N-甲基、N-乙基、N-丙基、N-异丙基、N-丁基、N-2-羟乙基、N-甲氧基丙基或N-2-羟丙基;可对R2进行选择,以提供例如椰油酰胺、硬脂酰胺、油酰胺、月桂酰胺、肉豆蔻酰胺、癸酰胺、棕榈酰胺、牛脂酰胺等。Z部分可以是1-脱氧葡糖基、2-脱氧果糖基、1-脱氧麦芽糖基、1-脱氧乳糖基、1-脱氧半乳糖基、1-脱氧甘露糖基、1-脱氧麦芽三糖基等。In the above formula, R can be, for example, N-methyl, N-ethyl, N-propyl, N-isopropyl, N-butyl, N-2-hydroxyethyl, N-methoxypropyl R can be selected to provide, for example, cocamide, stearamide, oleamide, lauramide, myristamide, capramide, palmitamide, tallowamide, and the like. The Z moiety can be 1-deoxyglucosyl, 2-deoxyfructosyl, 1-deoxymaltosyl, 1-deoxylactosyl, 1-deoxygalactosyl, 1-deoxymannosyl, 1-deoxymaltotriosyl wait.
最优选的多羟基脂肪酰胺具有如下通式:The most preferred polyhydroxy fatty acid amides have the general formula:
式中R1为甲基或甲氧基丙基;R2为C11-C17直链烷基或烯基。这些物质包括:N-月桂基-N-甲基葡糖酰胺、N-月桂基-N-甲氧基丙基葡糖酰胺、N-椰油基-N-甲基葡糖酰胺、N-椰油基-N-甲氧基丙基葡糖酰胺、N-棕榈基-N-甲氧基丙基葡糖酰胺、N-牛脂基-N-甲基葡糖酰胺或N-牛脂基-N-甲氧基丙基葡糖酰胺。In the formula, R 1 is methyl or methoxypropyl; R 2 is C 11- C 17 linear alkyl or alkenyl. These substances include: N-Lauryl-N-methylglucamide, N-Lauryl-N-methoxypropylglucamide, N-cocoyl-N-methylglucamide, N-coco Oleyl-N-methoxypropyl glucamide, N-palmityl-N-methoxypropyl glucamide, N-tallow-N-methyl glucamide or N-tallow-N- Methoxypropyl Glucamide.
正如前面所指出的那样,某些固定剂需要一乳化剂以有助于溶解在润滑剂中。特别是对于某些葡糖酰胺如HLB值至少约7的N-烷基-N-甲氧基丙基葡糖酰胺,更是如此。合适的乳化剂通常包括HLB值低于约7的那些物质。在这方面,业已发现先前所述的脱水山梨醇酯,如HLB值约为4.9或更小的硬脂酸脱水山梨醇酯可用来将这些葡糖酰胺固定剂溶解于凡士林中。其它合适的乳化剂包括:十八烷基聚氧乙烯醚-2(与结构式CH3(CH2)17(OCH2CH2)nOH相一致的硬脂醇的聚乙二醇醚,式中n的平均值为2)、脱水山梨醇三硬脂酸酯、月桂酸异山梨醇酯(isosorbide laurate)和甘油一硬脂酸酯。所述乳化剂的用量应足以使固定剂溶解于润滑剂中,以致能获得基本均匀的混合物。例如,当添加20%的、作为乳化剂的十八烷基聚氧乙烯醚-2和脱水山梨醇三硬脂酸酯的1∶1的混合物时,通常将不会熔入单相混合物中的N-椰子基-N-甲基葡糖酰胺和凡士林的约1∶1的混合物将熔入单相混合物中。As noted previously, some fixatives require an emulsifier to aid in dissolution in the lubricant. This is especially true for certain glucamides such as N-alkyl-N-methoxypropyl glucamides having an HLB value of at least about 7. Suitable emulsifiers generally include those having an HLB value below about 7. In this regard, it has been found that previously described sorbitan esters, such as sorbitan stearate having an HLB value of about 4.9 or less, can be used to dissolve these glucosamide fixatives in petrolatum. Other suitable emulsifiers include: stearyl polyoxyethylene ether-2 (polyethylene glycol ether of stearyl alcohol corresponding to the formula CH 3 (CH 2 ) 17 (OCH 2 CH 2 ) n OH, where The average value of n is 2), sorbitan tristearate, isosorbide laurate and glyceryl monostearate. The emulsifier is used in an amount sufficient to dissolve the fixative in the lubricant so that a substantially homogeneous mixture is obtained. For example, when 20% of a 1:1 mixture of stearyl-2 and sorbitan tristearate is added as an emulsifier, the An approximately 1:1 mixture of N-cocoyl-N-methylglucamide and petrolatum will melt into a single phase mixture.
或者单独使用,或者可与上述固定剂结合使用的、可用作固定剂的其它类型的成分包括蜡,如巴西棕榈蜡,蜂蜡,小烛树蜡,石蜡,地蜡,西班牙草蜡,小冠椰子蜡,rezowax和其它已知的蜡。优选的蜡是石蜡。特别优选的石蜡的一个实例是Parrafin S.P.434(得自Strahl and Pitsch Inc.P.O.Box 1098West Babylon,NY11704)。Other types of ingredients that can be used as fixatives, either alone or in combination with the above-mentioned fixatives, include waxes such as carnauba wax, beeswax, candelilla wax, paraffin wax, ozokerite, Spanish grass wax, coronet Coconut wax, rezowax and other known waxes. A preferred wax is paraffin. An example of a particularly preferred paraffin is Parrafin S.P. 434 (available from Strahl and Pitsch Inc. P.O. Box 1098 West Babylon, NY 11704).
应加入组合物中的任选固定剂的量将取决于各种因素,包括涉及的活性物质(如润滑剂)、所涉及的特定的固定剂(如果存在的话)、组合物中的其它组分、是否需要乳化剂将固定剂溶解于其它成分中等因素。如果使用固定剂,则组合物通常将包含约5%至约90%的固定剂。优选的是,组合物将包含约5%至约50%,最优选约10%至约40%的固定剂。The amount of optional fixative that should be added to the composition will depend on various factors including the actives involved (such as lubricants), the particular fixative involved (if present), other components in the composition , whether an emulsifier is needed to dissolve the fixative in other components, etc. If a fixative is used, the composition will generally comprise from about 5% to about 90% fixative. Preferably, the composition will comprise from about 5% to about 50%, most preferably from about 10% to about 40%, of a fixative.
当然,非常希望至少一部分用品的结构化的载体由亲水性材料制成以促进液体(如尿液)快速输送通过结构化的载体。类似地,希望组合物应是可充分润湿的以确保液体快速输送通过结构化的载体。或者,可以使用疏水性护肤组合物,只要施用它们以使得可足够保持结构化的载体的流体处理性能。(例如,如下面所讨论的那样,将组合物不均匀地施用到结构化的载体上是实现该目标的一个方法。)这就减少了身体排出物将流出组合物-经处理的结构化的载体,而不是被引导通过结构化的载体并被吸湿芯吸收的可能性。Of course, it is highly desirable that at least a portion of the structured carrier of the article be made of a hydrophilic material to facilitate rapid transport of liquids, such as urine, through the structured carrier. Similarly, it is desirable that the composition should be sufficiently wettable to ensure rapid liquid transport through the structured carrier. Alternatively, hydrophobic skin care compositions may be used as long as they are applied such that the fluid handling properties of the structured carrier are adequately maintained. (For example, as discussed below, applying the composition unevenly to the structured carrier is one way to achieve this goal.) This reduces the amount of bodily exudates that will flow out of the composition-treated structured carrier, rather than the possibility of being guided through a structured carrier and absorbed by the absorbent core.
在需要亲水性组合物时,取决于组合物中所用的具体组分,可以需要或不需要亲水表面活性剂(或亲水表面活性剂的混合物)以改善润湿性。例如,某些固定剂如N-椰油基-N-甲氧基丙基葡糖酰胺的HLB值至少约7,在不加入亲水性表面活性剂的情况下是可充分润湿的。当将组合物施加到用品的结构化的载体上时,其它固定剂,如HLB值约小于7的C16-C18脂肪醇可能需要加入亲水性表面活性剂以改进润湿性。类似地,疏水性润滑剂如凡士林可能需要加入亲水性表面活性剂,如果亲水性表面活性剂是需要的话。当然,当所考虑的接触穿用者的表面不是用品的结构化的载体时或者当结构化的载体的流体处理性能可通过其它方式(如非均匀施加)得以充分保持的话,润湿性问题将不是-个因素。Where hydrophilic compositions are desired, a hydrophilic surfactant (or mixture of hydrophilic surfactants) may or may not be required to improve wettability, depending on the particular components used in the composition. For example, certain fixatives, such as N-coco-N-methoxypropylglucamide, have an HLB value of at least about 7 and are sufficiently wettable without the addition of hydrophilic surfactants. Other fixatives, such as C16- C18 fatty alcohols with HLB values less than about 7, may require the addition of hydrophilic surfactants to improve wettability when the composition is applied to the structured support of the article. Similarly, hydrophobic lubricants such as petrolatum may require the addition of a hydrophilic surfactant, if a hydrophilic surfactant is desired. Of course, when the surface in contact with the wearer is not the structured carrier of the article or when the fluid handling properties of the structured carrier can be adequately maintained by other means (such as non-uniform application), the wettability problem will not be - factor.
合适的亲水性表面活性剂优选可与护肤组合物中的其它成分混溶,形成共混的混合物。由于使用施加有组合物的一次性吸湿产品可能会使皮肤敏感,因此,这些表面活性剂还应是对皮肤而言是柔和和无刺激性的。通常,这些亲水表面活性剂是非离子型的,其不仅是对皮肤无刺激性的,而且将避免对被处理的用品内的任何其它结构的不利影响。例如,薄纸层压物的拉伸强度、粘合剂粘结充分性的降低等。Suitable hydrophilic surfactants are preferably miscible with the other ingredients of the skin care composition to form a blended mixture. These surfactants should also be mild and non-irritating to the skin since use of the disposable absorbent product to which the composition is applied may sensitize the skin. Typically, these hydrophilic surfactants are non-ionic which are not only non-irritating to the skin but which will avoid adverse effects on any other structure within the article being treated. For example, reduction in tensile strength of tissue laminates, adequacy of adhesive bonds, etc.
在组合物施加至用品上之后,合适的非离子表面活性剂基本上是不迁移的,并且通常具有约4至约20、优选约7至约20的HLB值。要成为不迁移的,这些非离子表面活性剂通常将具有高于在一次性吸湿用品的储存、运输、交易以及使用期间所遇到的温度的熔化温度,例如至少约30℃。就这一点而言,这些非离子表面活性剂优选将具有类似于前述固定剂的熔点。Suitable nonionic surfactants are substantially non-migrating after the composition has been applied to the article and typically have an HLB value of from about 4 to about 20, preferably from about 7 to about 20. To be non-migratory, these nonionic surfactants will generally have a melting temperature above the temperatures encountered during storage, transport, trade and use of disposable absorbent articles, for example at least about 30°C. In this regard, these nonionic surfactants will preferably have melting points similar to the aforementioned fixatives.
用于将要施加到用品上、至少在尿布的液体排泄区内的组合物中的、合适的非离子表面活性剂包括:烷基苷;烷基苷醚,如在引入本发明作为参考的1977年3月8日授予Langdon等人的美国专利4,011,389中披露的;烷基聚乙氧基化的酯如Pegosperse 1000MS(得自Lonza,Inc.,Fair Lawn,NewJersey),平均乙氧基化度从约2至约20、优选从约2至约10的C12-C18脂肪酸的乙氧基化的脱水山梨醇一酯、二酯和/或三酯,如TWEEN 60(平均乙氧基化度约20的硬脂酸脱水山梨醇酯)、TWEEN 61(平均乙氧基化度约4的硬脂酸脱水山梨醇酯),以及脂族醇与约1至约54摩尔环氧乙烷的缩合产物。所述脂族醇的烷基链通常是直链的(线性的)构形并包含约8至约22个碳原子。特别优选的是包含约11至约22个碳原子的烷基的醇与每摩尔醇约2至约30摩尔的环氧乙烷的缩合产物。所述乙氧基化醇的例子包括:肉豆蔻醇与每摩尔醇7摩尔环氧乙烷的缩合产物,椰子醇(烷基链长度在10-14个碳原子之间变化的脂肪醇的混合物)与约6摩尔环氧乙烷的缩合产物。许多合适的乙氧基化醇可从市场得到,它们包括TERGITOL 15-S-9(C11-C15线性醇与9摩尔环氧乙烷的缩合产物),由联合碳化物公司出售;KYRO EOB(C13-C15线性醇与9摩尔环氧乙烷的缩合产物),由The Procter & Gamble Co.出售;品名为NEODOL的表面活性剂(由壳牌化学公司出售),特别是NEODOL 25-12(C12-C15线性醇与12摩尔环氧乙烷的缩合产物)和NEODOL 23-6.5T(C12-C13线性醇与已蒸馏(拔顶)除去某些杂质的6.5摩尔环氧乙烷的缩合产物);尤其是品名为PLURAFAC的表面活性剂(由BASF公司出售),特别是PLURAFAC A-38(C18直链醇与27摩尔环氧乙烷的缩合产物)。(某些亲水表面活性剂,特别是乙氧基化醇如NEODOL 25-12也能起烷基乙氧基化润滑剂的作用)。优选的乙氧基化醇表面活性剂的其它例子包括:ICI类的Brij表面活性剂及其混合物,其中Brij72(即十八烷基聚氧乙烯醚-2)和Brij76(即十八烷基聚氧乙烯醚-10)是特别优选的。另外,乙氧基化至平均乙氧基化度约10至约20的鲸蜡醇和硬脂醇的混合物也可用作亲水表面活性剂。Suitable nonionic surfactants for use in compositions to be applied to the article, at least in the liquid release zone of the diaper, include: alkyl glycosides; alkyl glycoside ethers, as described in 1977, incorporated herein by reference Disclosed in U.S. Patent 4,011,389 issued to Langdon et al. on March 8; alkyl polyethoxylated esters such as Pegosperse 1000MS (available from Lonza, Inc., Fair Lawn, New Jersey), with an average degree of ethoxylation ranging from about 2 to about 20, preferably from about 2 to about 10 ethoxylated sorbitan monoesters, diesters and/or triesters of C 12 -C 18 fatty acids, such as TWEEN 60 (average degree of ethoxylation approx. 20 sorbitan stearate), TWEEN 61 (sorbitan stearate with an average degree of ethoxylation of about 4), and condensation products of aliphatic alcohols with about 1 to about 54 moles of ethylene oxide . The alkyl chain of the aliphatic alcohol is generally in a straight (linear) configuration and contains from about 8 to about 22 carbon atoms. Particularly preferred are condensation products of alcohols containing alkyl groups of about 11 to about 22 carbon atoms with about 2 to about 30 moles of ethylene oxide per mole of alcohol. Examples of such ethoxylated alcohols include: the condensation product of myristyl alcohol with 7 moles of ethylene oxide per mole of alcohol, coconut alcohol (a mixture of fatty alcohols with alkyl chain lengths varying between 10 and 14 carbon atoms), ) is the condensation product of about 6 moles of ethylene oxide. A number of suitable ethoxylated alcohols are commercially available including TERGITOL 15-S-9 (a condensation product of a C 11 -C 15 linear alcohol with 9 moles of ethylene oxide), sold by Union Carbide; KYRO EOB (condensation product of a C13 - C15 linear alcohol with 9 moles of ethylene oxide), sold by The Procter & Gamble Co.; surfactants under the name NEODOL (sold by Shell Chemical Company), especially NEODOL 25-12 (Condensation product of C 12 -C 15 linear alcohol with 12 moles of ethylene oxide) and NEODOL 23-6.5T (C 12 -C 13 linear alcohol with 6.5 moles of ethylene oxide that has been distilled (topped) to remove certain impurities Condensation products of alkanes); especially the surfactants under the name PLURAFAC (sold by the company BASF), especially PLURAFAC A-38 (condensation product of C 18 linear alcohol with 27 moles of ethylene oxide). (Certain hydrophilic surfactants, especially ethoxylated alcohols such as NEODOL 25-12 can also function as alkyl ethoxylated lubricants). Other examples of preferred ethoxylated alcohol surfactants include: Brij surfactants of the ICI class and mixtures thereof, wherein Brij 72 (i.e. stearyl polyoxyethylene ether-2) and Brij 76 (i.e. stearyl polyoxyethylene ether-2) Oxyethylene ether-10) is particularly preferred. Additionally, mixtures of cetyl and stearyl alcohols ethoxylated to an average degree of ethoxylation of from about 10 to about 20 are also useful as hydrophilic surfactants.
用于组合物中的另一类合适的表面活性剂包括:由American CyanamidCompany出售的Aerosol OT,即丁二酸二辛酯磺酸钠。Another class of suitable surfactants for use in the composition includes: Aerosol OT, sodium dioctyl succinate sulfonate, sold by the American Cyanamid Company.
用于组合物中的还有一类合适的表面活性剂包括:硅氧烷共聚物如General Electric SF 1188(聚二甲基硅氧烷和聚氧亚烷基醚的共聚物)和General Electric SF 1228(硅氧烷聚醚共聚物)。这些硅氧烷表面活性剂能与上述其它种类的亲水表面活性剂如乙氧基化醇结合使用。业已发现,这些硅氧烷表面活性剂在低至组合物重量的0.1%,更优选约0.25-1.0%的浓度时是有效的。A further class of suitable surfactants for use in the compositions includes: silicone copolymers such as General Electric SF 1188 (a copolymer of polydimethylsiloxane and polyoxyalkylene ether) and General Electric SF 1228 (siloxane polyether copolymer). These silicone surfactants can be used in combination with the other classes of hydrophilic surfactants mentioned above, such as ethoxylated alcohols. These silicone surfactants have been found to be effective at concentrations as low as 0.1%, more preferably from about 0.25% to about 1.0%, by weight of the composition.
当需要亲水性组合物时,增加组合物的润湿性至理想程度所需的亲水表面活性剂的量将部分取决于所使用的固定剂的HLB值和用量、所使用的表面活性剂的HLB值等因素。当需要增加组合物的润湿性时,组合物可包含约0.1至约50%、优选约1至约25%、最优选约10至约20%的亲水表面活性剂。When a hydrophilic composition is desired, the amount of hydrophilic surfactant required to increase the wettability of the composition to the desired level will depend in part on the HLB value and amount of the fixative used, the surfactant used The HLB value and other factors. When desired to increase the wettability of the composition, the composition may contain from about 0.1 to about 50%, preferably from about 1 to about 25%, most preferably from about 10 to about 20%, of a hydrophilic surfactant.
组合物还包含通常存在于此类的乳液、膏、软膏、润肤液、粉末、悬浮剂等中的其它组分。这些组分包括水、粘度调节剂、香料、消毒杀菌活性剂、抗病毒剂、维生素、药用活性剂、成膜剂、除臭剂、遮光剂、收敛剂、溶剂、防腐剂等。另外,可以加入稳定剂以增加组合物的储存期限,如纤维素衍生物、蛋白质和卵磷脂。所有这些物质用作所述配方的添加剂在本领域是熟知的,并以合适的量用在本发明所用的组合物中。The compositions also contain other ingredients normally present in such emulsions, creams, ointments, lotions, powders, suspensions and the like. These components include water, viscosity modifiers, fragrances, antiseptic actives, antiviral agents, vitamins, pharmaceutical actives, film formers, deodorants, sunscreens, astringents, solvents, preservatives, and the like. Additionally, stabilizers may be added to increase the shelf life of the composition, such as cellulose derivatives, proteins and lecithin. All of these materials are well known in the art for use as additives to such formulations and are used in suitable amounts in the compositions used in the present invention.
若使用水基护肤组合物,则需要防腐剂。合适的防腐剂包括但不限于:羟苯甲酸丙酯、羟苯甲酸甲酯、苄醇、苄基二甲基氯化铵(benzylkonnium)、三元磷酸钙、丁基化羟基甲苯(BHT)或酸类如柠檬酸、酒石酸、马来酸、乳酸、苹果酸、苯甲酸、水杨酸等。合适的粘度增加剂包括用作有效的固定剂中的一些试剂。其它合适的粘度增加剂包括:烷基半乳甘露聚糖、二氧化硅、滑石、硅酸镁、山梨醇、胶体二氧化硅、硅酸铝镁、硬脂酸锌、羊毛蜡醇、脱水山梨糖醇(sorbiton)、倍半油酸酯(sesquioleate)、十六烷基羟乙基纤维素和其它改性的纤维素。合适的溶剂包括丙二醇,甘油,环聚二甲基硅氧烷,聚乙二醇,已二醇,二元醇或多羟基溶剂。合适的维生素包括A、D3、E、B5和E乙酸酯。If water-based skin care compositions are used, preservatives are required. Suitable preservatives include, but are not limited to: propylparaben, methylparaben, benzyl alcohol, benzylkonnium chloride, tribasic calcium phosphate, butylated hydroxytoluene (BHT) or Acids such as citric acid, tartaric acid, maleic acid, lactic acid, malic acid, benzoic acid, salicylic acid, etc. Suitable viscosity increasing agents include agents which are useful in fixatives. Other suitable viscosity increasing agents include: alkyl galactomannans, silicon dioxide, talc, magnesium silicate, sorbitol, colloidal silicon dioxide, magnesium aluminum silicate, zinc stearate, lanolin alcohol, sorbitan Sorbiton, sesquioleate, cetyl hydroxyethyl cellulose and other modified celluloses. Suitable solvents include propylene glycol, glycerin, cyclomethicone, polyethylene glycol, hexylene glycol, glycols or polyhydric solvents. Suitable vitamins include A, D3, E, B5 and E acetate.
在制备本发明的产品时,将润肤液组合物施加到样品的结构化的载体的外表面(即,朝向身体的表面)上。可以使用均匀分布具有熔融或液体稠度的润滑材料的任何一种涂布方法。合适的方法包括:喷洒、印刷(例如胶版印刷)、涂布(例如凹版涂布)、挤出或这些涂布技术的结合,例如将护肤组合物喷洒至旋转的表面如轧辊上,然后再将该组合物转移至用品的结构化的载体的外表面上。In preparing the products of the present invention, the lotion composition is applied to the outer surface (ie, the body-facing surface) of the structured carrier of the sample. Any coating method that evenly distributes the lubricating material having a molten or liquid consistency can be used. Suitable methods include: spraying, printing (such as offset printing), coating (such as gravure coating), extrusion or a combination of these coating techniques, such as spraying the skin care composition onto a rotating surface such as a roller, and then applying The composition is transferred to the outer surface of the structured carrier of the article.
由于结构化的载体具有有效的开孔面积和多个具有充分的有效尺寸的孔,所以不管已经施加至结构化的载体上的护肤组合物的量是多少,尿液和低粘度粪便可以渗透结构化的载体。因此,即使结构化的载体完全被护肤组合物饱和,尿液和低粘度粪便将会容易地在其中渗透通过,因为载体的这个结构正好在所施用的护肤组合物的区域之间产生了充分的分离,使流体不受阻碍地渗透过载体。通过提供结构化的载体已经解决了闭塞的问题,该载体具有有效的开孔面积和多个具有充分有效尺寸的孔。Because the structured carrier has an effective open area and a plurality of pores of sufficient effective size, urine and low-viscosity feces can penetrate the structure regardless of the amount of skin care composition that has been applied to the structured carrier the carrier of transformation. Thus, even if a structured carrier is fully saturated with the skin care composition, urine and low-viscosity feces will easily penetrate through it because the structure of the carrier creates sufficient space between the areas where the skin care composition is applied. Separation allows fluid to permeate unhindered through the carrier. The problem of occlusion has been solved by providing a structured support with an effective open area and a plurality of pores of sufficient effective size.
需要将有效量的组合物施用到结构化的载体上以减少BM对皮肤的粘附性并且/或者给穿用者提供皮肤功效。施用到用品的结构化的载体上的组合物的用量优选是约0.1毫克/英寸2至约35毫克/英寸2。据信,该用量的组合物足以赋予结构化的载体所需的治疗和/或保护性功效。An effective amount of the composition needs to be applied to the structured carrier to reduce the adhesion of the BM to the skin and/or to provide skin benefits to the wearer. The composition is preferably applied to the structured carrier of the article in an amount of about 0.1 mg/ in2 to about 35 mg/ in2 . This amount of composition is believed to be sufficient to impart the desired therapeutic and/or protective efficacy to the structured carrier.
既然已经解决了闭塞的问题,所以组合物可以以任何所需的方式施加到结构化的载体的外表面上。例如,可以将组合物施加到整个外表面或仅其部分上。也可将组合物不均匀地施加到结构化的载体的外表面上。“不均匀”指的是组合物的用量、分布的位置和图案等在结构化的载体表面上可以变化。例如,结构化的载体的经处理的表面的某些部分可具有更多或更少量的组合物,包括其上没有任何组合物的表面部分。Now that the problem of occlusion has been resolved, the composition can be applied to the outer surface of the structured carrier in any desired manner. For example, the composition can be applied to the entire exterior surface or only a portion thereof. The composition may also be applied non-uniformly to the outer surface of the structured carrier. "Non-uniform" means that the amount, location and pattern of distribution, etc., of the composition can vary across the surface of the structured support. For example, certain portions of the treated surface of the structured support may have greater or lesser amounts of the composition, including portions of the surface that do not have any composition thereon.
可以在组装期间的任何时刻将组合物施加到用品上。例如,可以在一次性吸湿用品包装前,将组合物施加到一次性吸湿产品成品的结构化的载体上。也可以在与其它原料组合以形成一次性吸湿产品成品前,将组合物施加到结构化的载体上。The composition can be applied to the article at any point during assembly. For example, the composition may be applied to the structured carrier of the finished disposable absorbent product prior to packaging of the disposable absorbent product. The composition may also be applied to a structured carrier before being combined with other materials to form the finished disposable absorbent product.
通常将熔融状态的组合物施加到用品的结构化的载体上。由于组合物在明显高于环境温度的温度下熔融,通常以加热的涂层的形式将组合物施加到结构化的载体上。通常,在施加到用品的结构化的载体上之前,将组合物加热到温度范围为约35-100℃、优选约40-90℃。一旦已经将熔融的组合物施加到用品的结构化的载体上,使其冷却并固化以形成结构化的载体表面上的固化的涂层或薄膜。优选设计施加方法以有助于组合物的冷却/固定。Typically the composition is applied in a molten state to the structured support of the article. Since the compositions melt at temperatures significantly above ambient temperature, the compositions are usually applied to the structured support in the form of a heated coating. Typically, the composition is heated to a temperature in the range of about 35-100°C, preferably about 40-90°C, prior to application to the structured support of the article. Once the molten composition has been applied to the structured support of the article, it is allowed to cool and solidify to form a cured coating or film on the surface of the structured support. The method of application is preferably designed to facilitate cooling/fixing of the composition.
尿布20可进一步含有改善液体和其它身体排泄物的容纳性能的弹性线制的腿部收口(未示出)。每个弹性线制的腿部收口可以含有几个降低腿部区域内身体排泄物泄漏的不同实施方案。(腿部收口可以是并有时也称为腿带、侧翼、阻挡收口或弹性收口。)美国专利3,860,003描述了一种一次性尿布20,其提供具有侧翼和一个或多个弹性件的可收缩的腿部开口以提供弹性线制的腿部收口(密封收口)。普通转让的1990年3月20日授予Aziz等人的美国专利4,909,803,题目为“具有弹性线制的翼的一次性吸湿用品”,描述了具有“直立的”弹性线制的翼(阻挡收口)以改善腿部区域的容纳性能的一次性尿布20。普通转让的1987年9月22日授予Lawson的美国专利4,695,278,题目为“具有双重收口的吸湿用品”,描述了具有双重收口包括密封收口和阻挡收口的一次性尿布20。The diaper 20 may further include elasticized leg cuffs (not shown) for improved containment of liquids and other body exudates. Each elasticized leg cuff may contain several different embodiments for reducing bodily leakage in the leg region. (The leg cuffs may be and are sometimes referred to as leg cuffs, side flaps, barrier cuffs, or elastic cuffs.) US Patent 3,860,003 describes a disposable diaper 20 that provides a collapsible diaper with side flaps and one or more elastic members. Leg openings to provide elasticated leg cuffs (sealed cuffs). Commonly assigned U.S. Patent 4,909,803, issued March 20, 1990 to Aziz et al., entitled "Disposable Absorbent Articles Having Elasticized Wings," describes having "upstanding" elasticated wings (barrier cuffs) Disposable diaper 20 for improved containment in the leg area. Commonly assigned US Patent 4,695,278, issued September 22, 1987 to Lawson, entitled "Absorbent Article Having Dual Closures," describes a disposable diaper 20 having dual closures including sealing and barrier cuffs.
尿布20优选进一步包括提供改善的贴合和容纳性能的弹性腰部件(未示出)。弹性腰部件是预期将弹性伸展和收缩以动态贴合穿用者的腰部的尿布20的部分或区域。弹性腰部件至少从吸湿芯28的至少一个腰部边缘纵向向外伸展,并通常形成尿布20的至少一部分端边。一次性尿布通常构造成具有两个弹性腰部件,一个布置在第一腰区27,另一个布置在第二腰区29,尽管尿布也可以构造成只有一个弹性腰部件。而且,尽管弹性腰部件或其任何构成元件可以含有固定到尿布20上的独立的元件,但弹性腰部件优选构造成尿布20的其它元件的延伸部分如底片26或结构化的载体24,优选底片26和结构化的载体24两者。弹性线制的腰带34可以构造成许多不同的构型,包括1985年5月7日授予Kievit等人的USP4,515,595和上面参考的US专利申请序列号07/715,152,将这些文献引入本发明作为参考。The diaper 20 preferably further includes an elastic waist feature (not shown) to provide improved fit and containment. The elastic waist feature is the portion or area of the diaper 20 that is expected to elastically expand and contract to dynamically fit the wearer's waist. The elastic waist feature extends longitudinally outwardly from at least one waist edge of the absorbent core 28 and generally forms at least a portion of the ends of the diaper 20 . Disposable diapers are typically constructed with two elastic waist features, one disposed in the first waist region 27 and the other disposed in the second waist region 29, although the diaper may also be constructed with only one elastic waist feature. Moreover, although the elastic waist feature or any of its constituent elements may comprise separate elements secured to the diaper 20, the elastic waist feature is preferably constructed as an extension of other elements of the diaper 20 such as the backsheet 26 or structured carrier 24, preferably the backsheet 26 and structured carrier 24 both. The elasticated waistband 34 can be constructed in many different configurations, including USP 4,515,595 issued May 7, 1985 to Kievit et al. and above-referenced US Patent Application Serial No. 07/715,152, which are incorporated herein as refer to.
尿布20还含有形成侧闭合的紧固体系36,其将第一腰区27和第二腰区29保持在重叠的构型,从而将侧向张力保持在尿布20的周边以将尿布20保持在穿用者上。典型的紧固体系公开在下列文献中:1989年7月11日授予Scripps的美国专利4,846,815,题目为“具有改进的紧固装置的一次性尿布”;1990年1月16日授予Nestegard的美国专利4,894,060,题目为“具有改进的勾紧固部分的一次性尿布”;1990年8月7日授予Battrell的普通转让的美国专利4,946,527,题目为“压敏胶紧固件及其制备方法”;1974年11月19日授予Buell的普通转让的美国专利3,848,594,题目为“一次性尿布的带紧固体系”;1987年5月5日授予Hirotsu等人的普通转让的美国专利B1 4,662,875,题目为“吸湿用品”;和本文前面所参考的美国专利申请07/715,152,将这些文献中的每一篇引入本发明作为参考。The diaper 20 also contains a side closure forming fastening system 36 which maintains the first waist region 27 and the second waist region 29 in an overlapping configuration thereby maintaining lateral tension at the periphery of the diaper 20 to hold the diaper 20 in a on the wearer. Typical fastening systems are disclosed in: U.S. Patent 4,846,815, issued Jul. 11, 1989 to Scripps, entitled "Disposable Diapers with Improved Fastening Means"; U.S. Pat. 4,894,060, entitled "Disposable Diapers Having Improved Hook Fastening Portions"; commonly assigned U.S. Patent 4,946,527, entitled "Pressure Sensitive Adhesive Fasteners and Methods of Making Same," issued Aug. 7, 1990 to Battrell; 1974 Commonly assigned U.S. Patent 3,848,594, issued November 19, 1987 to Buell, entitled "Tape Fastening System for Disposable Diapers"; commonly assigned U.S. Patent B1 4,662,875, issued May 5, 1987 to Hirotsu et al. Absorbent Article"; and US Patent Application Serial No. 07/715,152, previously referenced herein, each of which is incorporated herein by reference.
优选通过下列步骤将尿布20施用到穿用者上,即,将一个腰区、优选第二腰区29放置在穿用者的背部,并将尿布20的其余部分拉到穿用者的两腿之间以便将另一腰区、优选第一腰区27放置在穿用者的前部。然后,从防粘部分(release portion)撤去紧固体系的胶带片26。然后,施用尿布的人将弹性线制的侧片包裹在穿用者周围,同时仍抓住胶带片部分。将紧固体系固定到尿布20的外表面以实施两侧的闭合。The diaper 20 is preferably applied to the wearer by placing a waist region, preferably the second waist region 29, on the back of the wearer and pulling the rest of the diaper 20 over the wearer's legs between them so as to place another waist region, preferably the first waist region 27, on the front of the wearer. The tape piece 26 of the fastening system is then removed from the release portion. The person applying the diaper then wraps the elasticized side panels around the wearer while still grasping the tape portion. The fastening system is secured to the outer surface of the diaper 20 to effect closure on both sides.
尽管已经图示并描述了本发明的具体实施方案,但对于本领域普通技术人员而言很明显的是:在不偏离本发明的实质和范围的情况下,可以对本发明作出各种其它的改变和变化。因此,所附的权利要求书将覆盖在本发明范围内的所有这些改变和改进。While particular embodiments of the present invention have been illustrated and described, it would be obvious to those skilled in the art that various other changes can be made in the invention without departing from the spirit and scope of the invention. and change. It is therefore intended to cover in the appended claims all such changes and modifications that are within the scope of this invention.
Claims (16)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 97182507 CN1198547C (en) | 1997-11-14 | 1997-11-14 | Disposable absorbent article with skin care composition on apertured top sheet |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 97182507 CN1198547C (en) | 1997-11-14 | 1997-11-14 | Disposable absorbent article with skin care composition on apertured top sheet |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1286605A CN1286605A (en) | 2001-03-07 |
CN1198547C true CN1198547C (en) | 2005-04-27 |
Family
ID=5178553
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 97182507 Expired - Lifetime CN1198547C (en) | 1997-11-14 | 1997-11-14 | Disposable absorbent article with skin care composition on apertured top sheet |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1198547C (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112512475A (en) * | 2018-08-03 | 2021-03-16 | 宝洁公司 | Fibrous web having composition thereon |
EP3829509B1 (en) | 2018-08-03 | 2023-12-13 | The Procter & Gamble Company | Webs with compositions applied thereto |
CN111388201A (en) * | 2019-11-19 | 2020-07-10 | 浙江珍琦护理用品有限公司 | Paper diaper capable of absorbing solid excrement |
EP4088700A4 (en) * | 2020-03-25 | 2024-01-17 | Daio Paper Corporation | WEARABLE DISPOSABLE ITEM |
-
1997
- 1997-11-14 CN CN 97182507 patent/CN1198547C/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
CN1286605A (en) | 2001-03-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6498284B1 (en) | Disposable absorbent article with a skin care composition on an apertured top sheet | |
JP4637371B2 (en) | Absorbent article having skin care composition | |
JP4463419B2 (en) | Web material with two or more skin care compositions and products made therefrom | |
JP4926355B2 (en) | Articles having movable breathable skin care compositions | |
KR100374314B1 (en) | An absorbent article for improving skin condition | |
KR100374313B1 (en) | An absorbent article for maintaining or improving skin health | |
US6476288B1 (en) | Absorbent articles having cuffs and topsheet with skin care composition(s) disposed thereon | |
US6676646B2 (en) | Zoned disposable absorbent article for urine and low-viscosity fecal material | |
CN1198681A (en) | Diapers with a lotion topsheet containing liquid polyol polyester lubricant and fixative | |
JPH10509896A (en) | Diapers with lotion-applied topsheets | |
JPH10509895A (en) | Diaper having a topsheet coated with a lotion containing a polysiloxane emollient | |
JP4948702B2 (en) | Disposable absorbent products having a skin care composition on a perforated topsheet | |
CN1245438A (en) | Absorbent articles having lotioned leg cuffs | |
WO1998024390A9 (en) | Absorbent articles having cuffs with skin care composition disposed thereon | |
JP2002513643A (en) | Absorbent product having a skin care composition disposed thereon | |
CN1121241C (en) | Absorbent articles having cuffs with skin-care composition disposed thereon | |
CN1257433A (en) | Absobent articles having lotioned leg cuffs containing a polysiloxane emollient | |
CN1198547C (en) | Disposable absorbent article with skin care composition on apertured top sheet | |
WO1999025287A1 (en) | Zoned disposable absorbent article for urine and low-viscosity fecal material | |
KR100267877B1 (en) | Diaper having a lotioned topsheet | |
MXPA00004729A (en) | Disposable absorbent article with a skin care composition on an apertured top sheet | |
KR100267876B1 (en) | Diaper having a lotioned topsheet containing a polysiloxane emollient | |
MXPA00004724A (en) | Zoned disposable absorbent article for urine and low-viscosity fecal material |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CX01 | Expiry of patent term |
Granted publication date: 20050427 |